SYNOPSYS INC, 10-Q filed on 8/19/2022
Quarterly Report
v3.22.2.2
Document and Entity Information - shares
9 Months Ended
Jul. 31, 2022
Aug. 17, 2022
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jul. 31, 2022  
Document Transition Report false  
Entity File Number 000-19807  
Entity Registrant Name SYNOPSYS, INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 56-1546236  
Entity Address, Address Line One 690 EAST MIDDLEFIELD ROAD  
Entity Address, City or Town MOUNTAIN VIEW  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94043  
City Area Code 650  
Local Phone Number 584-5000  
Title of 12(b) Security Common Stock(par value of $0.01 per share)  
Trading Symbol SNPS  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   152,911,344
Amendment Flag false  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q3  
Entity Central Index Key 0000883241  
Current Fiscal Year End Date --10-31  
v3.22.2.2
Unaudited Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jul. 31, 2022
Oct. 31, 2021
Current assets:    
Cash and cash equivalents $ 1,383,559 $ 1,432,840
Short-term investments 147,599 147,949
Total cash, cash equivalents and short-term investments 1,531,158 1,580,789
Accounts receivable, net 682,647 568,501
Inventories 219,736 229,023
Prepaid and other current assets 465,487 430,028
Total current assets 2,899,028 2,808,341
Property and equipment, net 486,872 472,398
Operating lease right-of-use assets, net 574,501 493,251
Goodwill 3,854,889 3,575,785
Intangible assets, net 404,652 279,132
Deferred income taxes 617,429 612,655
Other long-term assets 492,176 510,698
Total assets 9,329,547 8,752,260
Current liabilities:    
Accounts payable and accrued liabilities 736,099 741,191
Operating lease liabilities, current 54,170 79,678
Deferred revenue 1,755,594 1,517,623
Short-term debt 0 74,992
Total current liabilities 2,545,863 2,413,484
Operating lease liabilities, non-current 592,930 487,003
Long-term deferred revenue 164,964 136,303
Long-term debt 21,960 25,094
Other long-term liabilities 352,188 391,433
Total liabilities 3,677,905 3,453,317
Redeemable non-controlling interest 43,516 0
Stockholders’ equity:    
Preferred stock, $0.01 par value: 2,000 shares authorized; none outstanding 0 0
Common stock, $0.01 par value: 400,000 shares authorized; 153,004 and 153,062 shares outstanding, respectively 1,530 1,531
Capital in excess of par value 1,415,244 1,576,363
Retained earnings 5,377,586 4,549,713
Treasury stock, at cost: 4,257 and 4,198 shares, respectively (1,034,841) (782,866)
Accumulated other comprehensive income (loss) (155,493) (49,604)
Total Synopsys stockholders’ equity 5,604,026 5,295,137
Non-controlling interest 4,100 3,806
Total stockholders’ equity 5,608,126 5,298,943
Total liabilities, redeemable non-controlling interest and stockholders’ equity $ 9,329,547 $ 8,752,260
v3.22.2.2
Unaudited Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Jul. 31, 2022
Oct. 31, 2021
Statement of Financial Position [Abstract]    
Preferred Stock, par value (in USD per share) $ 0.01 $ 0.01
Preferred Stock, shares authorized (in shares) 2,000,000 2,000,000
Preferred Stock, shares outstanding (in shares) 0 0
Common Stock, par value (in USD per share) $ 0.01 $ 0.01
Common Stock, shares authorized (in shares) 400,000,000 400,000,000
Common Stock, shares outstanding (in shares) 153,004,000 153,062,000
Treasury stock, shares (in shares) 4,257,000 4,198,000
v3.22.2.2
Unaudited Condensed Consolidated Statements Of Income - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Jul. 31, 2022
Jul. 31, 2021
Jul. 31, 2022
Jul. 31, 2021
Revenue:        
Total revenue $ 1,247,766 $ 1,057,130 $ 3,797,250 $ 3,051,774
Cost of revenue:        
Amortization of intangible assets 19,330 11,870 47,145 35,164
Total cost of revenue 271,181 205,066 780,976 627,051
Gross margin 976,585 852,064 3,016,274 2,424,723
Operating expenses:        
Research and development 444,826 371,146 1,218,761 1,090,959
Sales and marketing 199,246 171,428 571,329 514,810
General and administrative 91,461 83,846 246,426 234,028
Amortization of intangible assets 7,124 8,570 23,036 25,273
Restructuring charges 0 15,151 12,057 15,151
Total operating expenses 742,657 650,141 2,071,609 1,880,221
Operating income 233,928 201,923 944,665 544,502
Other income (expense), net 2,426 11,414 (41,280) 61,934
Income before income taxes 236,354 213,337 903,385 606,436
Provision for income taxes 16,708 14,945 76,506 51,214
Net income 219,646 198,392 826,879 555,222
Net income (loss) attributed to non-controlling interest and redeemable non-controlling interest (2,980) (254) (4,215) (847)
Net income attributed to Synopsys $ 222,626 $ 198,646 $ 831,094 $ 556,069
Net income per share attributed to Synopsys:        
Basic (in USD per share) $ 1.46 $ 1.30 $ 5.43 $ 3.64
Diluted (in USD per share) $ 1.43 $ 1.27 $ 5.31 $ 3.54
Shares used in computing per share amounts:        
Basic (shares) 152,938 152,635 153,082 152,619
Diluted (shares) 155,806 156,907 156,545 157,158
Time-based products        
Revenue:        
Total revenue $ 754,322 $ 665,563 $ 2,185,626 $ 1,945,647
Cost of revenue:        
Cost of revenue 164,077 127,592 480,166 389,677
Upfront products        
Revenue:        
Total revenue 268,584 203,301 973,483 586,798
Maintenance and service        
Revenue:        
Total revenue 224,860 188,266 638,141 519,329
Cost of revenue:        
Cost of revenue $ 87,774 $ 65,604 $ 253,665 $ 202,210
v3.22.2.2
Unaudited Condensed Consolidated Statements Of Comprehensive Income - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jul. 31, 2022
Jul. 31, 2021
Jul. 31, 2022
Jul. 31, 2021
Statement of Comprehensive Income [Abstract]        
Net income $ 219,646 $ 198,392 $ 826,879 $ 555,222
Other comprehensive income (loss):        
Change in foreign currency translation adjustment (23,378) (5,905) (63,989) 8,857
Changes in unrealized gains (losses) on available-for-sale securities, net of tax of $0 for periods presented (1) 15 (1,674) 15
Cash flow hedges:        
Deferred gains (losses), net of tax $6,780 and $16,191, for the three and nine months ended July 31, 2022, respectively, and of $(909) and $(1,876) for each of the same periods in fiscal 2021, respectively. (19,051) 3,664 (41,769) 8,971
Reclassification adjustment on deferred (gains) losses included in net income, net of tax of $(28) and $(499), for the three and nine months ended July 31, 2022, respectively, and of $1,460 and $3,808 for each of the same periods in fiscal 2021, respectively. 36 (4,830) 1,543 (12,180)
Other comprehensive income (loss), net of tax effects (42,394) (7,056) (105,889) 5,663
Comprehensive income 177,252 191,336 720,990 560,885
Less: net income (loss) attributed to non-controlling interest and redeemable non-controlling interest (2,980) (254) (4,215) (847)
Comprehensive income attributed to Synopsys $ 180,232 $ 191,590 $ 725,205 $ 561,732
v3.22.2.2
Unaudited Condensed Consolidated Statements Of Comprehensive Income (Parenthetical) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jul. 31, 2022
Jul. 31, 2021
Jul. 31, 2022
Jul. 31, 2021
Statement of Comprehensive Income [Abstract]        
Deferred gains (losses), tax $ 6,780 $ (909) $ 16,191 $ (1,876)
Reclassification adjustment on deferred (gains) losses included in net income, tax $ (28) $ 1,460 $ (499) $ 3,808
v3.22.2.2
Unaudited Condensed Consolidated Statements of Stockholders' Equity Statement - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
[1]
Common Stock
Capital in Excess of Par Value
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
[1]
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Total  Synopsys Stockholders’ Equity
Total  Synopsys Stockholders’ Equity
Cumulative Effect, Period of Adoption, Adjustment
Non-controlling Interest
Balance (in shares) at Oct. 31, 2020     152,618                
Beginning balance at Oct. 31, 2020 $ 4,912,367   $ 1,528 $ 1,653,166 $ 3,795,397   $ (488,613) $ (54,074) $ 4,907,404   $ 4,963
Beginning balance (Retained earnings adjustment due to adoption of ASC 326) at Oct. 31, 2020   $ (3,200)       $ (3,200)       $ (3,200)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 555,222       556,069       556,069   (847)
Other comprehensive income (loss), net of tax effects $ 5,663             5,663 5,663    
Purchases of treasury stock (in shares) (2,114) [2]   (2,114)                
Purchases of treasury stock $ (538,082) [2]   $ (21) 21     (538,082)   (538,082)    
Equity forward contract, net $ (35,000)     (35,000)         (35,000)    
Common stock issued, net of shares withheld for employee taxes (in shares) 2,093 [2]   2,093                
Common stock issued, net of shares withheld for employee taxes $ 9,636   $ 19 (259,737)     269,354   9,636    
Stock-based compensation 248,530     248,530         248,530    
Balance (in shares) at Jul. 31, 2021     152,597                
Ending balance at Jul. 31, 2021 5,155,136   $ 1,526 1,606,980 4,348,266   (757,341) (48,411) 5,151,020   4,116
Balance (in shares) at Apr. 30, 2021     152,554                
Beginning balance at Apr. 30, 2021 5,092,505   $ 1,526 1,679,801 4,149,620   (701,457) (41,355) 5,088,135   4,370
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 198,392       198,646       198,646   (254)
Other comprehensive income (loss), net of tax effects $ (7,056)             (7,056) (7,056)    
Purchases of treasury stock (in shares) (521) [2]   (521)                
Purchases of treasury stock $ (140,000) [2]   $ (5) 5     (140,000)   (140,000)    
Equity forward contract, net $ (35,000)     (35,000)         (35,000)    
Common stock issued, net of shares withheld for employee taxes (in shares) 564 [2]   564                
Common stock issued, net of shares withheld for employee taxes $ (38,867)   $ 5 (122,988)     84,116   (38,867)    
Stock-based compensation 85,162     85,162         85,162    
Balance (in shares) at Jul. 31, 2021     152,597                
Ending balance at Jul. 31, 2021 5,155,136   $ 1,526 1,606,980 4,348,266   (757,341) (48,411) 5,151,020   4,116
Balance (in shares) at Oct. 31, 2021     153,062                
Beginning balance at Oct. 31, 2021 5,298,943   $ 1,531 1,576,363 4,549,713   (782,866) (49,604) 5,295,137   3,806
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 830,100       831,094       831,094   (994)
Other comprehensive income (loss), net of tax effects $ (105,889)             (105,889) (105,889)    
Purchases of treasury stock (in shares) (2,400) [3]   (2,400)                
Purchases of treasury stock $ (752,266) [3]   $ (24) 24     (752,266)   (752,266)    
Equity forward contract, net $ (5,000)     (5,000)         (5,000)    
Common stock issued, net of shares withheld for employee taxes (in shares) 2,342 [3]   2,342                
Common stock issued, net of shares withheld for employee taxes $ 12,022   $ 23 (488,292)     500,291   12,022    
Stock-based compensation 333,437     332,149         332,149   1,288
Adjustments to redeemable non-controlling interest (3,221)       (3,221)       (3,221)    
Balance (in shares) at Jul. 31, 2022     153,004                
Ending balance at Jul. 31, 2022 5,608,126   $ 1,530 1,415,244 5,377,586   (1,034,841) (155,493) 5,604,026   4,100
Balance (in shares) at Apr. 30, 2022     152,955                
Beginning balance at Apr. 30, 2022 5,567,430   $ 1,530 1,517,481 5,157,633   (999,234) (113,099) 5,564,311   3,119
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 222,319       222,626       222,626   (307)
Other comprehensive income (loss), net of tax effects $ (42,394)             (42,394) (42,394)    
Purchases of treasury stock (in shares) (715) [3]   (715)                
Purchases of treasury stock $ (217,266) [3]   $ (8) 8     (217,266)   (217,266)    
Equity forward contract, net $ (40,000)     (40,000)         (40,000)    
Common stock issued, net of shares withheld for employee taxes (in shares) 764 [3]   764                
Common stock issued, net of shares withheld for employee taxes $ (6,895)   $ 8 (188,562)     181,659   (6,895)    
Stock-based compensation 127,605     126,317         126,317   1,288
Adjustments to redeemable non-controlling interest (2,673)       (2,673)       (2,673)    
Balance (in shares) at Jul. 31, 2022     153,004                
Ending balance at Jul. 31, 2022 $ 5,608,126   $ 1,530 $ 1,415,244 $ 5,377,586   $ (1,034,841) $ (155,493) $ 5,604,026   $ 4,100
[1] At the beginning of fiscal 2021, we adopted the Accounting Standards Codification (ASC) 326, Measurement of Credit Losses on Financial Instruments, issued by the Financial Accounting Standards Board (FASB). ASC 326 replaced the incurred loss methodology with an expected loss methodology.
[2] Excluded the 99,573 shares and $35.0 million equity forward contract from the June 2021 ASR settled in August 2021.
[3] Excluded the 101,821 shares and $40.0 million equity forward contract from the May 2022 ASR settled in August 2022.
v3.22.2.2
Unaudited Condensed Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Jul. 31, 2022
Jul. 31, 2021
Cash flow from operating activities:    
Net income attributed to Synopsys $ 831,094 $ 556,069
Adjustments to reconcile net income to net cash provided by operating activities:    
Amortization and depreciation 169,708 151,274
Reduction of operating lease right-of-use assets 65,980 64,920
Amortization of capitalized costs to obtain revenue contracts 54,438 46,973
Stock-based compensation 333,437 248,530
Allowance for credit losses (4,516) 13,813
Deferred income taxes 5,843 (33,116)
Other non-cash 6,141 2,936
Net changes in operating assets and liabilities, net of acquired assets and liabilities:    
Accounts receivable (121,786) 188,996
Inventories 118 (51,448)
Prepaid and other current assets (56,075) (62,201)
Other long-term assets (20,058) (117,922)
Accounts payable and accrued liabilities (46,356) 51,991
Operating lease liabilities (66,187) (61,666)
Income taxes (60,739) (29,414)
Deferred revenue 254,353 152,328
Net cash provided by operating activities 1,345,395 1,122,063
Cash flows from investing activities:    
Proceeds from sales and maturities of short-term investments 70,847 1,128
Purchases of short-term investments (73,330) (146,082)
Proceeds from sales of long-term investments 582 0
Purchases of long-term investments (7,000) (7,591)
Purchases of property and equipment (102,934) (66,957)
Cash paid for acquisitions, net of cash acquired (416,323) (164,053)
Capitalization of software development costs (1,970) (1,517)
Other (1,200) (800)
Net cash used in investing activities (531,328) (385,872)
Cash flows from financing activities:    
Repayment of debt (76,838) (21,637)
Issuances of common stock 161,416 113,976
Payments for taxes related to net share settlement of equity awards (149,130) (104,291)
Purchase of equity forward contract (40,000) (35,000)
Purchases of treasury stock (717,266) (538,082)
Other (3,413) (4,375)
Net cash used in financing activities (825,231) (589,409)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (38,155) 2,985
Net change in cash, cash equivalents and restricted cash (49,319) 149,767
Cash, cash equivalents and restricted cash, beginning of year 1,435,183 1,237,970
Cash, cash equivalents and restricted cash, end of period $ 1,385,864 $ 1,387,737
v3.22.2.2
Description of Business
9 Months Ended
Jul. 31, 2022
Accounting Policies [Abstract]  
Description of Business Description of Business
Synopsys, Inc. (Synopsys, we, our or us) provides products and services used across the entire Silicon to Software spectrum, from engineers creating advanced semiconductors to software developers seeking to ensure the security and quality of their code.
We are a global leader in electronic design automation (EDA) software that engineers use to design and test integrated circuits (ICs), also known as chips. We also offer semiconductor intellectual property (IP) products, which are pre-designed circuits that engineers use as components of larger chip designs rather than designing those circuits themselves. We provide software and hardware used to validate the electronic systems that incorporate chips and the software that runs on them. We also provide technical services and support to help our customers develop advanced chips and electronic systems. These products and services are part of our Semiconductor & System Design segment.
We are also a leading provider of software tools and services that improve the security, quality and compliance of software in a wide variety of industries, including electronics, financial services, automotive, medicine, energy and industrials. These tools and services are part of our Software Integrity segment.
v3.22.2.2
Summary of Significant Accounting Policies
9 Months Ended
Jul. 31, 2022
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
We have prepared the accompanying unaudited condensed consolidated financial statements pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Pursuant to these rules and regulations, we have condensed or omitted certain information and footnote disclosures we normally include in our annual consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP). In management’s opinion, we have made all adjustments (consisting only of normal, recurring adjustments, except as otherwise indicated) necessary to fairly present our unaudited condensed consolidated balance sheets, results of operations, comprehensive income, stockholders’ equity and cash flows. Our interim period operating results do not necessarily indicate the results that may be expected for any other interim period or for the full fiscal year. These financial statements and accompanying notes should be read in conjunction with the consolidated financial statements and notes thereto in our Annual Report on Form 10-K for the fiscal year ended October 31, 2021 as filed with the SEC on December 13, 2021 (our Annual Report).
Use of Estimates. To prepare financial statements in conformity with U.S. GAAP, management must make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Actual results could differ from these estimates and may result in material effects on our operating results and financial position.
Principles of Consolidation. The unaudited condensed consolidated financial statements include our accounts and the accounts of our subsidiaries. All intercompany accounts and transactions have been eliminated.
Fiscal Year End. Our fiscal year generally ends on the Saturday nearest to October 31 and consists of 52 weeks, with the exception that approximately every five years, we have a 53-week year. When a 53-week year occurs, we include the additional week in the first quarter to realign fiscal quarters with calendar quarters. Fiscal 2022 and 2021 are both 52-week years. Fiscal 2022 will end on October 29, 2022. Fiscal 2021 ended on October 30, 2021. For presentation purposes, the unaudited condensed consolidated financial statements and accompanying notes refer to the closest calendar month end.
Significant Accounting Policies. There have been no material changes to our significant accounting policies included in our Annual Report, other than our accounting policy for redeemable non-controlling interest.
Redeemable Non-controlling Interest. Non-controlling interest that is not solely redeemable within our control is reported as the temporary equity in our unaudited condensed consolidated balance sheets. The carrying value of the redeemable non-controlling interest equals the redemption value at the end of each reporting period, after giving effect to the change from the net income (loss) attributable to the redeemable non-controlling interest. We adjust the redemption value of the non-controlling interest on a quarterly basis and changes in the estimated redemption value are recorded with corresponding adjustments against retained earnings.
Recently Adopted Accounting Pronouncements
In December 2019, the FASB issued Accounting Standards Update (ASU) 2019-12, Simplifying the Accounting for Income Taxes, which simplifies the accounting for income taxes, eliminates certain exceptions within ASC 740, Income Taxes, and clarifies certain aspects of the current guidance to promote consistency among reporting entities. We adopted the standard as of the beginning of fiscal 2022 on a prospective basis and the adoption of this standard did not have a material impact on our unaudited condensed consolidated financial statements.
In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The new guidance requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers, as if the acquirer had originated the contracts. We early adopted the standard in the second quarter of fiscal 2022 and the adoption had no material impact on our unaudited condensed consolidated financial statements for acquisitions completed in the first two quarters of fiscal 2022. The adoption of ASU 2021-08 resulted in the recognition of deferred revenue at amounts consistent with those recorded by the acquiree immediately before the acquisition date rather than at fair value for the business acquisition completed in the third quarter of fiscal 2022. See Note 4. Business Combinations for further information.
Recently Issued Accounting Pronouncements
In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (ASU 2022-03), which applies to all equity securities measured at fair value that are subject to contractual sale restrictions. This change prohibits entities from taking into account contractual restrictions on the sale of equity securities when estimating fair value and introduces required disclosures for such transactions. The standard will become effective for us beginning on November 1, 2024 and should be applied prospectively. Early adoption is permitted. The adoption of this guidance is not expected to have a material impact on our unaudited condensed consolidated financial statements.
v3.22.2.2
Revenue
9 Months Ended
Jul. 31, 2022
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
Disaggregated Revenue
The following table showed the percentage of revenue by product groups:
Three Months Ended 
 July 31,
Nine Months Ended 
 July 31,
2022202120222021
EDA50.0 %55.8 %49.9 %56.2 %
IP & System Integration39.7 %34.4 %40.7 %34.2 %
Software Integrity Products & Services9.5 %9.3 %8.9 %9.3 %
Other0.8 %0.5 %0.5 %0.3 %
Total100.0 %100.0 %100.0 %100.0 %
Contract Balances
The contract assets indicated below are presented as prepaid and other current assets in the unaudited condensed consolidated balance sheets. The contract assets are transferred to receivables when the rights to invoice and receive payment become unconditional. Unbilled receivables are presented as accounts receivable, net, in the unaudited condensed consolidated balance sheets.
Contract balances were as follows:
As of
July 31, 2022October 31, 2021
 (in thousands)
Contract assets, net$280,507 $284,574 
Unbilled receivables$41,863 $35,589 
Deferred revenue$1,920,558 $1,653,926 
During the three and nine months ended July 31, 2022, we recognized revenue of $171.2 million and $1.1 billion, respectively, that was included in the deferred revenue balance as of October 31, 2021.
Contracted but unsatisfied or partially unsatisfied performance obligations were approximately $7.1 billion as of July 31, 2022, which includes $998.1 million in non-cancellable Flexible Spending Account (FSA) commitments from customers where actual product selection and quantities of specific products or services are to be determined by customers at a later date. We have elected to exclude future sales-based royalty payments from the remaining performance obligations. Approximately 42% of the contracted but unsatisfied or partially unsatisfied performance obligations as of July 31, 2022, excluding non-cancellable FSA, are expected to be recognized over the next 12 months, with the remainder recognized thereafter.
During the three and nine months ended July 31, 2022, we recognized $33.9 million and $103.5 million, respectively, from performance obligations satisfied from sales-based royalties earned during the periods. During the three and nine months ended July 31, 2021, we recognized $27.9 million and $88.7 million, respectively, from performance obligations satisfied from sales-based royalties earned during the periods.
Costs of Obtaining a Contract with Customer
Capitalized commission costs, net of accumulated amortization, as of July 31, 2022 were $105.0 million and included in other long-term assets in our unaudited condensed consolidated balance sheets. Amortization of these assets was $19.9 million and $54.4 million during the three and nine months ended July 31, 2022, respectively, and included in sales and marketing expense in our unaudited condensed consolidated statements of income. Amortization of these assets was $16.5 million and $47.0 million during the three and nine months ended July 31, 2021, respectively, and included in sales and marketing expense in our unaudited condensed consolidated statements of income.
v3.22.2.2
Business Combinations
9 Months Ended
Jul. 31, 2022
Business Combinations [Abstract]  
Business Combinations Business Combinations
On June 22, 2022, we completed the acquisition of all outstanding shares of NTT Security AppSec Solutions Inc. (which has operated under the name WhiteHat Security, or WhiteHat), a provider of dynamic application security testing solutions, from NTT Security Corporation for an aggregate purchase price of $330.1 million in cash. With this acquisition, we have broadened our product offering in the application security testing market.
Preliminary Purchase Price Allocation
The aggregate purchase consideration was preliminarily allocated as follows:
(in thousands)
Total purchase consideration$330,112 
Less: cash acquired22,849 
Total purchase consideration, net of cash acquired$307,263 
Allocations
Goodwill$247,734 
Intangible assets97,500 
Deferred revenue(40,367)
Other tangible assets, net2,396 
$307,263 
The goodwill was primarily attributed to increased synergies that are expected to be achieved from the integration of WhiteHat. The $247.7 million of goodwill was assigned to the Software Integrity reporting unit and the amount recognized was not deductible for tax purposes. The acquired identifiable intangible assets of $97.5 million were valued using the income or cost approach. The intangible assets are being amortized over their respective useful lives ranging from 5 to 10 years.
Other Fiscal 2022 Acquisitions
During the three months ended January 31, 2022, we completed an acquisition for purchase consideration of $20.0 million, net of cash acquired. The preliminary purchase price was allocated as follows: $4.3 million to identifiable intangible assets and $15.7 million to goodwill, which were attributable to the Semiconductor & System Design reporting unit. There was no tax-deductible goodwill related to the acquisition.
During the three months ended April 30, 2022, we acquired 75% equity interest in OpenLight Photonics, Inc. (OpenLight) for cash consideration of $90.0 million. The remaining 25% equity interest in OpenLight is held by Juniper Networks, Inc. (the Minority Investor) from their contribution of IP and certain tangible assets.
The agreement with the Minority Investor contains redemption features whereby the interest held by the Minority Investor is redeemable either (i) at the option of the Minority Investor on or after the third anniversary of the acquisition or sooner in certain circumstances or (ii) at our option beginning on the third anniversary of the acquisition. This option is exercisable at the greater of fair value at the time of redemption or $30.0 million and was valued at $10.1 million, resulting in a total consideration of $100.1 million.
The preliminary purchase price was allocated as follows: $94.0 million to identifiable intangible assets and $45.1 million to goodwill, which were attributable to the Semiconductor & System Design reporting unit. The goodwill was mainly attributable to the assembled workforce and planned growth in new markets. There was no tax-deductible goodwill related to the acquisition.
From the date of acquisition through July 31, 2022, OpenLight incurred a net loss of $12.9 million, of which $3.2 million was attributable to redeemable non-controlling interest. As of July 31, 2022, the carrying amount of the redeemable non-controlling interest was recorded at its estimated fair value of $43.5 million in the unaudited condensed consolidated balance sheets.
We have included the financial results of these acquisitions in our unaudited condensed consolidated financial statements from the date of acquisition. We do not consider these acquisitions to be material, individually or in the aggregate, to our unaudited condensed consolidated financial statements.
Preliminary Fair Value Estimates
For all acquisitions completed, the purchase price was allocated to tangible and identifiable intangible assets acquired and liabilities assumed based on their preliminary estimated fair values, which were determined using generally accepted valuation techniques based on estimates and assumptions made by management at the time of acquisition. These estimates and assumptions are subject to change as additional information becomes available during the respective measurement period, which is not expected to exceed 12 months from applicable acquisition date.
Acquisition-Related Transaction Costs
Transaction costs were $5.2 million and $11.3 million during the three and nine months ended July 31, 2022, respectively. Transaction costs were $5.7 million and $11.6 million during the three and nine months ended July 31, 2021, respectively. These costs mainly consisted of professional fees and administrative costs and were expensed as incurred in our unaudited condensed consolidated statements of income.
v3.22.2.2
Goodwill and Intangible Assets
9 Months Ended
Jul. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets Goodwill and Intangible Assets
Goodwill
The changes in the carrying amount of goodwill during the nine months ended July 31, 2022 were as follows:
 (in thousands)
Balance at October 31, 2021
$3,575,785 
Additions308,532 
Adjustments1,285 
Effect of foreign currency translation(30,713)
Balance at July 31, 2022
$3,854,889 
During the nine months ended July 31, 2022, we finalized certain estimates impacting total purchase consideration for certain acquisitions and recorded the resulting measurement period adjustments which increased goodwill.
Intangible Assets
Intangible assets as of July 31, 2022 consisted of the following:
Gross Carrying AmountAccumulated
Amortization
Net Amount
 (in thousands)
Core/developed technology$1,078,103 $793,937 $284,166 
Customer relationships423,739 328,459 95,280 
Contract rights intangible191,430 188,524 2,906 
Trademarks and trade names52,795 33,157 19,638 
Capitalized software development costs48,068 45,406 2,662 
Total$1,794,135 $1,389,483 $404,652 
Intangible assets as of October 31, 2021 consisted of the following:
Gross Carrying AmountAccumulated
Amortization
Net Amount
 (in thousands)
Core/developed technology$911,903 $748,759 $163,144 
Customer relationships404,571 308,355 96,216 
Contract rights intangible193,317 188,231 5,086 
Trademarks and trade names43,095 31,155 11,940 
Capitalized software development costs46,098 43,352 2,746 
Total$1,598,984 $1,319,852 $279,132 
Amortization expense related to intangible assets consisted of the following:
 Three Months Ended 
 July 31,
Nine Months Ended 
 July 31,
 2022202120222021
 (in thousands)
Core/developed technology$18,603 $11,431 $45,180 $33,416 
Customer relationships6,322 7,960 20,819 23,443 
Contract rights intangible727 439 2,180 1,748 
Trademarks and trade names802 610 2,002 1,830 
Capitalized software development costs(1)
619 1,010 2,052 3,120 
Total$27,073 $21,450 $72,233 $63,557 
(1) Amortization of capitalized software development costs is included in cost of products revenue in the unaudited condensed consolidated statements of income.
The following table presented the estimated future amortization of intangible assets as of July 31, 2022:
Fiscal year(in thousands)
Remainder of fiscal 2022$26,960 
202398,039 
202486,748 
202570,102 
202657,677 
2027 and thereafter65,126 
Total$404,652 
v3.22.2.2
Balance Sheets Components
9 Months Ended
Jul. 31, 2022
Balance Sheet Related Disclosures [Abstract]  
Balance Sheets Components Balance Sheets Components
As of
July 31, 2022October 31, 2021
(in thousands)
Other long-term assets:
Deferred compensation plan assets$295,415 $343,820 
Capitalized commission, net105,036 92,249 
Other long-term assets91,725 74,629 
Total$492,176 $510,698 
Accounts payable and accrued liabilities:
Payroll and related benefits$522,041 $581,687 
Other accrued liabilities142,060 132,091 
Accounts payable71,998 27,413 
Total$736,099 $741,191 
Other long-term liabilities:
Deferred compensation plan liabilities$295,413 $343,820 
Other long-term liabilities56,775 47,613 
Total$352,188 $391,433 
v3.22.2.2
Financial Assets and Liabilities
9 Months Ended
Jul. 31, 2022
Financial Assets And Liabilities [Abstract]  
Financial Assets and Liabilities Financial Assets and Liabilities
Short-term investments. Gross unrealized gains and losses on our available-for-sale debt securities as of July 31, 2022 were not significant. The stated maturities of our available-for-sale debt securities as of July 31, 2022 were as follows:

Amortized CostFair Value
(in thousands)
less than 1 year$72,253 $71,567 
1-5 years71,480 70,403 
5-10 years4,176 4,102 
>10 years1,610 1,527 
Total$149,519 $147,599 
As of July 31, 2022, the balances of our cash equivalents and short-term investments were as follows:
CostGross
Unrealized
Gains
Gross
Unrealized
Losses Less Than 12 Continuous Months
Gross
Unrealized
Losses 12 Continuous Months or Longer
Estimated
Fair Value
(1)
 (in thousands)
Cash equivalents:
Money market funds$94,796 $— $— $— $94,796 
Total:$94,796 $— $— $— $94,796 
Short-term investments:
U.S. government agency & T-bills$19,917 $$(117)$— $19,806 
Municipal bonds3,105 — (79)— 3,026 
Corporate debt securities98,318 30 (1,289)(108)96,951 
Asset-backed securities28,179 (328)(36)27,816 
Total:$149,519 $37 $(1,813)$(144)$147,599 
(1)See Note 8. Fair Value Measurements for further discussion on fair values of cash equivalents and short-term investments.
As of October 31, 2021, the balances of our cash equivalents and short-term investments were as follows:
CostGross
Unrealized
Gains
Gross
Unrealized
Losses Less Than 12 Continuous Months
Gross
Unrealized
Losses 12 Continuous Months or Longer
Estimated
Fair Value
(1)
 (in thousands)
Cash equivalents:
Money market funds$172,934 $— $— $— $172,934 
Total:$172,934 $— $— $— $172,934 
Short-term investments:
U.S. government agency & T-bills$6,447 $— $(5)$— $6,442 
Municipal bonds4,588 — (12)— 4,576 
Corporate debt securities103,615 (170)— 103,452 
Asset-backed securities33,545 (72)— 33,479 
Total:$148,195 $13 $(259)$— $147,949 
(1)See Note 8. Fair Value Measurements for further discussion on fair values of cash equivalents and short-term investments.
Restricted cash. We include amounts generally described as restricted cash and restricted cash equivalents in cash and cash equivalents when reconciling beginning-of-period and end-of-period total amounts shown on the unaudited condensed consolidated statements of cash flows. Restricted cash is primarily associated with office leases.
The following table provided a reconciliation of cash, cash equivalents and restricted cash included in the unaudited condensed consolidated balance sheets:
As of
July 31, 2022October 31, 2021
(in thousands)
Cash and cash equivalents$1,383,559 $1,432,840 
Restricted cash included in prepaid and other current assets1,594 1,560 
Restricted cash included in other long-term assets711 783 
Total cash, cash equivalents and restricted cash$1,385,864 $1,435,183 

Non-marketable equity securities. Our portfolio of non-marketable equity securities consists of strategic investments in privately held companies. There were no impairments of non-marketable equity securities during the three and
nine months ended July 31, 2022. There were no impairments of non-marketable equity securities during the three and nine months ended July 31, 2021.
Derivatives
We recognize derivative instruments as either assets or liabilities in the unaudited condensed consolidated balance sheets at fair value and provide qualitative and quantitative disclosures about such derivatives. We operate internationally and are exposed to potentially adverse movements in foreign currency exchange rates. We enter into hedges in the form of foreign currency forward contracts to reduce our exposure to foreign currency rate changes on non-functional currency denominated forecasted transactions and balance sheet positions including: (1) certain assets and liabilities, (2) shipments forecasted to occur within approximately one month, (3) future billings and revenue on previously shipped orders, and (4) certain future intercompany invoices denominated in foreign currencies.
The duration of forward contracts, the majority of which are short-term, ranges from approximately 1 month to 27 months at inception. We do not use foreign currency forward contracts for speculative or trading purposes. We enter into foreign exchange forward contracts with high credit quality financial institutions that are rated "A" or above and to date have not experienced nonperformance by counterparties. In addition, we mitigate credit risk in derivative transactions by permitting net settlement of transactions with the same counterparty and anticipate continued performance by all counterparties to such agreements.
The assets or liabilities associated with the forward contracts are recorded at fair value in other current assets or accrued liabilities in the unaudited condensed consolidated balance sheets. The accounting for gains and losses resulting from changes in fair value depends on the use of the foreign currency forward contract and whether it is designated and qualifies for hedge accounting. The cash flow impact upon settlement of the derivative contracts will be included in net cash provided by operating activities in the unaudited condensed consolidated statements of cash flows.
Cash Flow Hedging Activities
Certain foreign exchange forward contracts are designated and qualify as cash flow hedges. These contracts have durations of approximately 27 months or less. Certain forward contracts are rolled over periodically to capture the full length of exposure to our foreign currency risk, which can be up to three years. To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge, and the hedges must be highly effective in offsetting changes to future cash flows on the hedged transactions. The related gains or losses resulting from changes in fair value of these hedges is initially reported, net of tax, as a component of other comprehensive income (loss) (OCI) in stockholders’ equity and reclassified into revenue or operating expenses, as appropriate, at the time the hedged transactions affect earnings. We expect a minority of the hedge balance in OCI to be reclassified to the statements of income within the next 12 months.
We did not record any gains or losses related to discontinuation of cash flow hedges during the nine months ended July 31, 2022 and 2021.
Non-designated Hedging Activities
Our foreign exchange forward contracts that are used to hedge non-functional currency denominated balance sheet assets and liabilities are not designated as hedging instruments. Accordingly, any gains or losses from changes in the fair value of the forward contracts are recorded in other income (expense), net. The gains and losses on these forward contracts generally offset the gains and losses associated with the underlying assets and liabilities, which are also recorded in other income (expense), net. The duration of the forward contracts for hedging our balance sheet exposure is approximately one month.
We also have certain foreign exchange forward contracts for hedging certain international revenues and expenses that are not designated as hedging instruments. Accordingly, any gains or losses from changes in the fair value of the forward contracts are recorded in other income (expense), net. The gains and losses on these forward contracts generally offset the gains and losses associated with the foreign currency in operating income. The duration of these forward contracts is usually less than one year. The overall goal of our hedging program is to minimize the impact of currency fluctuations on the net income over the fiscal year.    
The effects of the non-designated derivative instruments on our unaudited condensed consolidated statements of income were summarized as follows:
 Three Months Ended 
 July 31,
Nine Months Ended 
 July 31,
 2022202120222021
 (in thousands)
Gains (losses) recorded in other income (expense), net$(5,182)$(837)$(10,443)$1,420 
The notional amounts in the table below for derivative instruments provided one measure of the transaction volume outstanding:
As of
July 31, 2022October 31, 2021
 (in thousands)
Total gross notional amounts$1,295,726 $1,176,152 
Net fair value$(13,289)$13,404 
Our exposure to the market gains or losses will vary over time as a function of currency exchange rates. The amounts ultimately realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments.
The following table represented the unaudited condensed consolidated balance sheets location and amount of derivative instrument fair values segregated between designated and non-designated hedge instruments:
Fair values of
derivative instruments
designated as hedging
instruments
Fair values of
derivative instruments
not designated as
hedging instruments
 (in thousands)
Balance at July 31, 2022
Other current assets$11,232 $1,510 
Accrued liabilities$25,975 $55 
Balance at October 31, 2021
Other current assets$15,455 $17 
Accrued liabilities$2,027 $42 
The following table represented the location of the amount of gains and losses on derivative instrument fair values for designated hedge instruments, net of tax in the unaudited condensed consolidated statements of income:

Location of gains (losses) recognized in OCI on derivativesAmount of gains (losses) recognized in OCI on
derivatives
(effective portion)
Location of
gains (losses)
reclassified from OCI
Amount of
gains (losses)
reclassified from
OCI
(effective portion)
 (in thousands)
Three months ended 
 July 31, 2022
Foreign exchange contractsRevenue$(4,702)Revenue$3,651 
Foreign exchange contractsOperating expenses(14,349)Operating expenses(3,687)
Total$(19,051)$(36)
Three months ended 
 July 31, 2021
Foreign exchange contractsRevenue$251 Revenue$1,563 
Foreign exchange contractsOperating expenses3,413 Operating expenses3,267 
Total$3,664 $4,830 
Nine months ended 
 July 31, 2022
Foreign exchange contractsRevenue$(12,527)Revenue$3,309 
Foreign exchange contractsOperating expenses(29,242)Operating expenses(4,852)
Total$(41,769)$(1,543)
Nine months ended 
 July 31, 2021
Foreign exchange contractsRevenue$1,892 Revenue$2,597 
Foreign exchange contractsOperating expenses7,079 Operating expenses9,583 
Total$8,971 $12,180 
v3.22.2.2
Fair Value Measurements
9 Months Ended
Jul. 31, 2022
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
ASC 820-10, Fair Value Measurements and Disclosures, defines fair value, establishes guidelines and enhances disclosure requirements for fair value measurements. The accounting guidance requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The accounting guidance also establishes a fair value hierarchy based on the independence of the source and objective evidence of the inputs used. There are three fair value hierarchies based upon the level of inputs that are significant to fair value measurement:
Level 1—Observable inputs that reflect quoted prices (unadjusted) for identical instruments in active markets;
Level 2—Observable inputs other than quoted prices included in Level 1 for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-driven valuations in which all significant inputs and significant value drivers are observable in active markets; and
Level 3—Unobservable inputs to the valuation derived from fair valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
On a recurring basis, we measure the fair value of certain of our assets and liabilities, which include cash equivalents, non-qualified deferred compensation plan assets, and foreign currency derivative contracts.
Our cash equivalents and short-term investments are classified within Level 1 or Level 2 because they are valued using quoted market prices in an active market or alternative independent pricing sources and models utilizing market observable inputs.
Our non-qualified deferred compensation plan assets consist of money market and mutual funds invested in domestic and international marketable securities that are directly observable in active markets and are therefore classified within Level 1.
Our foreign currency derivative contracts are classified within Level 2 because these contracts are not actively traded, and the valuation inputs are based on quoted prices and market observable data of similar instruments.
Our borrowings under the credit and term loan facilities are classified within Level 2 because these borrowings are not actively traded and have a variable interest rate structure based upon market rates currently available for our debt with similar terms and maturities. See Note 10. Credit and Term Loan Facilities for more information on these borrowings.
Assets/Liabilities Measured at Fair Value on a Recurring Basis
Assets and liabilities measured at fair value on a recurring basis were summarized below as of July 31, 2022:
  Fair Value Measurement Using
DescriptionTotalQuoted Prices in 
Active Markets
for Identical Assets
(Level 1)
Significant Other
Observable Inputs
(Level 2)
Significant
Unobservable
 Inputs
(Level 3)
 (in thousands)
Assets
Cash equivalents:
Money market funds$94,796 94,796 
Short-term investments:
U.S. government agency & T-bills19,806 19,806 
Municipal bonds3,026 3,026 
Corporate debt securities96,951 96,951 
Asset-backed securities27,816 27,816 
Prepaid and other current assets:
Foreign currency derivative contracts12,742 12,742 
Other long-term assets:
Deferred compensation plan assets295,415 295,415 
Total assets$550,552 $390,211 $160,341 $— 
Liabilities
Accounts payable and accrued liabilities:
Foreign currency derivative contracts$26,031 $26,031 
Other long-term liabilities:
Deferred compensation plan liabilities295,413 295,413 
Total liabilities$321,444 $295,413 $26,031 $— 
Assets and liabilities measured at fair value on a recurring basis were summarized below as of October 31, 2021:
  Fair Value Measurement Using
DescriptionTotalQuoted Prices in 
Active Markets
for Identical Assets
(Level 1)
Significant Other
Observable Inputs
(Level 2)
Significant
Unobservable 
Inputs
(Level 3)
 (in thousands)
Assets
Cash equivalents:
Money market funds$172,934 $172,934 
Short-term investments:
U.S. government agency & T-bills6,442 6,442 
Municipal bonds4,576 4,576 
Corporate debt securities103,452 103,452 
Asset-backed securities33,479 33,479 
Prepaid and other current assets:
Foreign currency derivative contracts15,472 15,472 
Other long-term assets:
Deferred compensation plan assets343,820 343,820 
Total assets$680,175 $516,754 $163,421 $— 
Liabilities
Accounts payable and accrued liabilities:
Foreign currency derivative contracts$2,068 $2,068 
Other long-term liabilities:
Deferred compensation plan liabilities343,820 343,820 
Total liabilities$345,888 $343,820 $2,068 $— 
Assets/Liabilities Measured at Fair Value on a Non-Recurring Basis
Non-Marketable Equity Securities
Non-marketable equity securities are classified within Level 3 as they are valued using significant unobservable inputs or data in an inactive market due to the absence of market price and inherent lack of liquidity.
v3.22.2.2
Restructuring Charges
9 Months Ended
Jul. 31, 2022
Payables and Accruals [Abstract]  
Restructuring Charges Restructuring Charges
In the third quarter of fiscal 2021, we initiated a restructuring plan for involuntary and voluntary employee termination and facility closure actions as part of a business reorganization (the 2021 Plan).
The 2021 Plan was substantially completed in the first quarter of fiscal 2022 and the total charges under the 2021 Plan were $45.5 million. During the three months ended July 31, 2022, we made payments of $0.9 million under the 2021 Plan. As of July 31, 2022, the outstanding restructuring related liabilities were immaterial and recorded in accounts payable and accrued liabilities in the unaudited condensed consolidated balance sheets.
v3.22.2.2
Credit and Term Loan Facilities
9 Months Ended
Jul. 31, 2022
Debt Disclosure [Abstract]  
Credit and Term Loan Facilities Credit and Term Loan Facilities
On January 22, 2021, we entered into a Fourth Extension and Amendment Agreement (the Fourth Amendment), which amended and restated our previous credit agreement, dated as of November 28, 2016 (as amended and restated, the Credit Agreement). Our outstanding borrowings under the previous credit agreement, which as of January 22, 2021 consisted of term loans in the aggregate principal amount of $97.5 million, were carried over under the Credit Agreement and fully repaid on November 26, 2021.
The Fourth Amendment extended the termination date of the existing $650.0 million senior unsecured revolving credit facility (the Revolver) from November 28, 2021 to January 22, 2024, which could be further extended at our option. The Credit Agreement also provides an uncommitted incremental loan facility of up to $150 million in the aggregate principal amount. The Credit Agreement contains financial covenants requiring us to maintain a maximum consolidated leverage ratio and a minimum consolidated interest coverage ratio, as well as other non-financial covenants. As of July 31, 2022, we were in compliance with all financial covenants.
There was no outstanding balance under the Revolver as of July 31, 2022 and October 31, 2021. We expect our borrowings, if any, under the Revolver will fluctuate from quarter to quarter. Borrowings bear interest at a floating rate based on a margin over our choice of market observable base rates as defined in the Credit Agreement. As of July 31, 2022, Revolver bore interest at LIBOR +1.000%. In addition, commitment fees are payable on the Revolver at rates between 0.125% and 0.200% per year based on our leverage ratio on the daily amount of the revolving commitment.
In July 2018, we entered into a 12-year 220.0 million Renminbi (approximately $33.0 million) credit agreement with a lender in China to support our facilities expansion. Borrowings bear interest at a floating rate based on the 5 year Loan Prime Rate plus 0.74%. As of July 31, 2022, we had $22.0 million outstanding balance under the agreement.
The carrying amount of the short-term and long-term debt approximates the estimated fair value. These borrowings under the Credit Agreement have a variable interest rate structure and are classified within Level 2 of the fair value hierarchy.
v3.22.2.2
Leases
9 Months Ended
Jul. 31, 2022
Leases [Abstract]  
Leases Leases
We have operating lease arrangements for office space, data center, equipment and other corporate assets. These leases have various expiration dates through December 31, 2040, some of which include options to extend the leases for up to 10 years. Because we are not reasonably certain to exercise these renewal options, the options are not considered in determining the lease term and associated potential option payments are excluded from lease payments.
The components of our lease expense during the period presented were as follows:
Three Months Ended July 31,Nine Months Ended July 31,
2022202120222021
(in thousands)
Operating lease expense (1)
$23,914 $23,843 $68,105 $70,818 
Variable lease expense (2)
2,910 2,184 7,904 5,361 
Total lease expense$26,824 $26,027 $76,009 $76,179 
(1) Operating lease expense includes immaterial amounts of short-term leases, net of sublease income.
(2) Variable lease expense includes payments to lessors that are not fixed or determinable at lease commencement date. These payments primarily consist of maintenance, property taxes, insurance and variable indexed based payments.
Supplemental cash flow information during the period presented was as follows:
Nine Months Ended July 31,
20222021
(in thousands)
Cash paid for amounts included in the measurement of operating lease liabilities$62,888 $64,516 
ROU assets obtained in exchange for operating lease liabilities$154,693 $92,149 
Lease term and discount rate information related to our operating leases as of the end of the period presented were as follows:
As of
July 31, 2022October 31, 2021
Weighted-average remaining lease term (in years)9.328.00
Weighted-average discount rate2.18 %2.01 %
The following represented the maturities of our future lease payments due under operating leases as of July 31, 2022:
Lease Payments
Fiscal year(in thousands)
Remainder of fiscal 2022$18,637 
202367,100 
202490,806 
202580,162 
202670,782 
2027 and thereafter400,021 
Total future minimum lease payments
727,508 
Less: Imputed interest80,408 
Total lease liabilities
$647,100 
In addition, certain facilities owned by us were leased to third parties under non-cancellable operating lease agreements. These leases have annual escalating payments and have expiration dates through March 31, 2031 in accordance with the terms and conditions of the existing agreement. The lease receipts from owned facilities, including sublease income from other facilities leased by us, due to us as of July 31, 2022 were as follows:
Lease Receipts
Fiscal year(in thousands)
Remainder of fiscal 2022$4,274 
202316,240 
202424,591 
202524,479 
202625,333 
2027 and thereafter110,189 
Total$205,106 
v3.22.2.2
Accumulated Other Comprehensive Income (Loss)
9 Months Ended
Jul. 31, 2022
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss)
The components of accumulated other comprehensive income (loss), on an after-tax basis where applicable, were as follows:
As of
July 31, 2022October 31, 2021
 (in thousands)
Cumulative currency translation adjustments$(112,037)$(48,047)
Unrealized gains (losses) on derivative instruments, net of taxes(41,536)(1,311)
Unrealized gains (losses) on available-for-sale securities, net of taxes(1,920)(246)
Total$(155,493)$(49,604)
The effect of amounts reclassified out of each component of accumulated other comprehensive income (loss) into net income was as follows:
 Three Months Ended 
 July 31,
Nine Months Ended 
 July 31,
 2022202120222021
 (in thousands)
Reclassifications:
Gains (losses) on cash flow hedges, net of taxes
Revenues$3,651 $1,563 $3,309 $2,597 
Operating expenses(3,687)3,267 (4,852)9,583 
Total$(36)$4,830 $(1,543)$12,180 
v3.22.2.2
Stock Repurchase Program
9 Months Ended
Jul. 31, 2022
Stock Repurchase Program [Abstract]  
Stock Repurchase Program Stock Repurchase Program
Our Board of Directors (the Board) approved a stock repurchase program (the Program) with authorization to purchase up to $1.0 billion of our common stock in December 2021. As of July 31, 2022, $242.7 million remained available for future repurchases under the Program.
In May 2022, we entered into an accelerated stock repurchase agreement (the May 2022 ASR) to repurchase an aggregate of $200.0 million of our common stock. Pursuant to the May 2022 ASR, we made a prepayment of $200.0 million to receive initial deliveries of shares valued at $160.0 million. The remaining balance of $40.0 million was settled in August 2022. Total shares purchased under the May 2022 ASR were approximately 0.6 million shares, at an average purchase price of $320.24 per share.
During the three months ended July 31, 2022, we also repurchased on the open market approximately 0.2 million shares of our common stock at an average price of $298.50 per share for an aggregate purchase price of $57.3 million.
Stock repurchase activities as well as the reissuance of treasury stock for employee stock-based compensation purposes were as follows:
 Three Months Ended 
 July 31,
Nine Months Ended 
 July 31,
 
2022 (1)
2021(2)
2022(1)
2021(2)
 (in thousands)
Total shares repurchased715 521 2,400 2,114 
Total cost of the repurchased shares$217,266 $140,000 $752,266 $538,082 
Reissuance of treasury stock764 564 2,342 2,093 
(1) Excluded the 101,821 shares and $40.0 million equity forward contract from the May 2022 ASR settled in August 2022.
(2) Excluded the 99,573 shares and $35.0 million equity forward contract from the June 2021 ASR settled in August 2021.
v3.22.2.2
Stock-Based Compensation
9 Months Ended
Jul. 31, 2022
Share-based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
The compensation cost recognized in the unaudited condensed consolidated statements of income for our stock compensation arrangements was as follows:
 Three Months Ended 
 July 31,
Nine Months Ended 
 July 31,
 2022202120222021
 (in thousands)
Cost of products$15,318 $9,582 $39,603 $28,238 
Cost of maintenance and service6,859 3,446 17,335 10,192 
Research and development expense68,243 42,430 175,892 124,231 
Sales and marketing expense22,998 15,330 60,090 45,040 
General and administrative expense14,187 14,374 40,517 40,829 
Stock-based compensation expense before taxes(1)
127,605 85,162 333,437 248,530 
Income tax benefit(20,940)(13,277)(54,717)(38,746)
Stock-based compensation expense after taxes$106,665 $71,885 $278,720 $209,784 
(1) During the three and nine months ended July 31, 2022, we recognized stock-based compensation expense relating to restricted stock units (RSUs), granted to senior executives in February 2022 with certain market, performance and service conditions (market-based RSUs). Under the award agreements, the vesting of the market-based RSUs is contingent on achieving total stockholder return (TSR) relative to a peer index as well as revenue growth metrics. The performance period during which the achievement goals will be measured is fiscal 2022 and fiscal 2023. The maximum potential awards that may be earned are 187.5% of the target number of the initial awards. The awards will vest in equal increments in December 2023 and December 2024 if the TSR target, revenue growth metrics, and service conditions are achieved. The grant date fair value for the market-based RSUs of $280.82 was determined using a Monte Carlo simulation model with the following assumptions: expected volatility of 33.01%, risk-free interest rate of 1.33% and an expected term of 1.69 years.
As of July 31, 2022, we had $1,057.7 million of total unrecognized stock-based compensation expense relating to options, RSUs and restricted stock awards, which is expected to be recognized over a weighted-average period of 2.4 years. As of July 31, 2022, we had $59.7 million of unrecognized stock-based compensation expense relating to our Employee Stock Purchase Plan (ESPP), which is expected to be recognized over a period of approximately 2.0 years.
The intrinsic values of equity awards exercised during the periods were as follows:
 Three Months Ended 
 July 31,
Nine Months Ended 
 July 31,
 2022202120222021
 (in thousands)
Intrinsic value of awards exercised$86,080 $30,896 $245,468 $143,100 
v3.22.2.2
Net Income per Share
9 Months Ended
Jul. 31, 2022
Earnings Per Share [Abstract]  
Net Income per Share Net Income Per ShareWe compute basic net income per share by dividing net income available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted net income per share reflects the dilution from potential common shares outstanding such as stock options and unvested RSUs and awards during the period using the treasury stock method.
The table below reconciled the weighted average common shares used to calculate basic net income per share with the weighted average common shares used to calculate diluted net income per share:
 Three Months Ended 
 July 31,
Nine Months Ended 
 July 31,
 2022202120222021
 (in thousands, except per share amounts)
Numerator:
Net income attributed to Synopsys$222,626 $198,646 $831,094 $556,069 
Denominator:
Weighted average common shares for basic net income per share152,938 152,635 153,082 152,619 
Dilutive effect of common share equivalents2,868 4,272 3,463 4,539 
Weighted average common shares for diluted net income per share155,806 156,907 156,545 157,158 
Net income per share attributed to Synopsys:
Basic$1.46 $1.30 $5.43 $3.64 
Diluted$1.43 $1.27 $5.31 $3.54 
Anti-dilutive employee stock-based awards excluded336 355 268 405 
v3.22.2.2
Segment Disclosure
9 Months Ended
Jul. 31, 2022
Segment Reporting [Abstract]  
Segment Disclosure Segment Disclosure
Segment reporting is based upon the “management approach,” i.e., how management organizes our operating segments for which separate financial information is (1) available and (2) evaluated regularly by the Chief Operating Decision Maker (CODM) in deciding how to allocate resources and in assessing performance. Until the second quarter of fiscal 2022, we had two CODMs, our two Co-Chief Executive Officers. One of our Co-Chief Executive Officers transitioned out of this role effective May 1, 2022. In the third quarter of fiscal 2022, our CODM was our Chief Executive Officer.
We have two reportable segments: (1) Semiconductor & System Design, which includes EDA tools, IP products, system integration solutions and other associated revenue categories, and (2) Software Integrity, which includes a comprehensive solution for building integrity—security, quality and compliance testing—into the customers’ software development lifecycle and supply chain.
The financial information provided to and used by the CODM to assist in making operational decisions, allocating resources, and assessing performance reflects consolidated financial information as well as revenue, adjusted operating income, and adjusted operating margin information for the Semiconductor & System Design and Software Integrity segments, accompanied by disaggregated information relating to revenue by geographic region.
Information by reportable segment was as follows:
 Three Months Ended 
 July 31,
Nine Months Ended 
 July 31,
 2022202120222021
 (in thousands)
Total Segments:
Revenue$1,247,766 $1,057,130 $3,797,250 $3,051,774 
Adjusted operating income392,127 337,396 1,321,671 941,456 
Adjusted operating margin31 %32 %35 %31 %
Semiconductor & System Design:
Revenue$1,129,427 $959,155 $3,458,499 $2,767,950 
Adjusted operating income380,871 328,742 1,285,391 916,434 
Adjusted operating margin34 %34 %37 %33 %
Software Integrity:
Revenue$118,339 $97,975 $338,751 $283,824 
Adjusted operating income11,256 8,654 36,280 25,022 
Adjusted operating margin10 %%11 %%
Certain operating expenses are not allocated to the segments and are managed at a consolidated level. The unallocated expenses managed at a consolidated level, including amortization of intangible assets, stock-based compensation and certain other operating expenses, were presented in the table below to provide a reconciliation of the total adjusted operating income from segments to our consolidated operating income:
 Three Months Ended 
 July 31,
Nine Months Ended 
 July 31,
 2022202120222021
 (in thousands)
Total segment adjusted operating income$392,127 $337,396 $1,321,671 $941,456 
Reconciling items:
Amortization of intangible assets(26,454)(20,440)(70,181)(60,437)
Stock-based compensation expense(127,605)(85,162)(333,437)(248,530)
Other(4,140)(29,871)26,612 (87,987)
Total operating income$233,928 $201,923 $944,665 $544,502 
The CODM does not use total assets by segment to evaluate segment performance or allocate resources. As a result, total assets by segment are not required to be disclosed.
In allocating revenue to particular geographic areas, the CODM considers where individual “seats” or licenses to our products are located. Revenue is defined as revenue from external customers. Revenue related to operations in the United States and other geographic areas were: 
 Three Months Ended 
 July 31,
Nine Months Ended 
 July 31,
 2022202120222021
 (in thousands)
Revenue:
United States$575,326 $477,218 $1,763,541 $1,417,636 
Europe127,288 112,877 376,195 324,212 
China189,138 164,172 617,524 405,460 
Korea125,307 110,536 358,871 314,178 
Other230,707 192,327 681,119 590,288 
Consolidated$1,247,766 $1,057,130 $3,797,250 $3,051,774 
Geographic revenue data for multi-regional, multi-product transactions reflect internal allocations and are therefore subject to certain assumptions and to our methodology.
v3.22.2.2
Other Income (Expense), Net
9 Months Ended
Jul. 31, 2022
Other Income and Expenses [Abstract]  
Other Income (Expense), Net Other Income (Expense), Net
The following table presented the components of other income (expense), net:
 Three Months Ended 
 July 31,
Nine Months Ended 
 July 31,
 2022202120222021
 (in thousands)
Interest income$2,735 $657 $4,876 $1,413 
Interest expense(439)(757)(1,339)(2,301)
Gains (losses) on assets related to deferred compensation plan(1,092)10,473 (50,001)62,697 
Foreign currency exchange gains (losses)(376)2,756 3,452 5,283 
Other, net1,598 (1,715)1,732 (5,158)
Total$2,426 $11,414 $(41,280)$61,934 
v3.22.2.2
Income Taxes
9 Months Ended
Jul. 31, 2022
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
Effective Tax Rate
We estimate our annual effective tax rate at the end of each fiscal quarter. The effective tax rate takes into account our estimations of annual pre-tax income, the geographic mix of pre-tax income and interpretations of tax laws and possible outcomes of audits.
The following table presented the provision for income taxes and the effective tax rates:
 Three Months Ended 
 July 31,
Nine Months Ended 
 July 31,
 2022202120222021
 (in thousands)
Income before income taxes$236,354 $213,337 $903,385 $606,436 
Provision for income taxes$16,708 $14,945 $76,506 $51,214 
Effective tax rate7.1 %7.0 %8.5 %8.4 %
Our effective tax rate for the nine months ended July 31, 2022 is lower than the statutory federal corporate tax rate of 21.0% primarily due to U.S. federal research tax credits, foreign-derived intangible income deduction, excess tax benefits from stock-based compensation, and U.S. foreign tax credits, partially offset by state taxes, the effect of non-deductible stock-based compensation, and higher taxes on certain foreign earnings.
Our effective tax rates for the three months and nine months ended July 31, 2022 are consistent with the same periods in fiscal 2021.
The timing of the resolution of income tax examinations, and the amounts and timing of various tax payments that are part of the settlement process, are highly uncertain. Variations in such amounts and/or timing could cause large fluctuations in the balance sheet classification of current and non-current assets and liabilities. We believe that in the coming 12 months, it is reasonably possible that either certain audits and ongoing tax litigation will conclude or the statute of limitations on certain state and foreign income and withholding taxes will expire, or both. Given the uncertainty as to ultimate settlement terms, the timing of payment and the impact of such settlements on other uncertain tax positions, the range of the estimated potential decrease in underlying unrecognized tax benefits is between $0 and $33 million.
Non-U.S. Examinations
Hungarian Tax Authority
In 2017, the Hungarian Tax Authority (the HTA) assessed withholding taxes of approximately $25.0 million and interest and penalties of $11.0 million, against our Hungary subsidiary (Synopsys Hungary). Synopsys Hungary contested the assessment with the Hungarian Administrative Court (Administrative Court). As required under Hungarian law, Synopsys Hungary paid the assessment and recorded a tax expense due to an unrecognized tax benefit of $17.4 million, which is net of estimated U.S. foreign tax credits. The Administrative Court found against
Synopsys Hungary, and we appealed to the Hungarian Supreme Court. During 2021, the Hungarian Supreme Court heard our appeal and remanded the case to the Administrative Court for further proceedings. The Administrative Court once again ruled against Synopsys Hungary and we filed another appeal with the Hungarian Supreme Court. The Hungarian Supreme Court heard our appeal on January 27, 2022, vacated the lower court's decision and remanded the case back to the Administrative Court for further proceedings. A hearing with the Administrative Court was held on June 30, 2022; the next hearing is scheduled for September 22, 2022.
We are also under examination by the tax authorities in certain other jurisdictions. No material assessments have been proposed in these examinations.
Legislative Developments
On August 16, 2022, the Inflation Reduction Act of 2022 (the IR Act) was enacted in the United States. The IR Act introduces a 15% minimum tax based primarily on global consolidated U.S. GAAP profits with a minimum threshold of $1 billion. The tax takes effect in Synopsys' 2024 fiscal year, with the $1 billion threshold measured as an average over three years commencing in the current fiscal year. Computation of the tax includes adjustments which, among others, provide for offset of income taxes paid or accrued in non-U.S. jurisdictions. The details of the computation will be subject to regulations to be issued by the Department of the Treasury. Synopsys will monitor regulatory developments and will continue to evaluate the impact, if any, of the minimum tax.

The IR Act includes provisions intended to mitigate climate change by, among others, providing tax credit incentives for reductions in greenhouse gas emissions. The details of implementation of these incentives are subject to regulations to be released by the Department of the Treasury. Synopsys is monitoring these developments and will continue to evaluate opportunities to utilize these incentives in the future.

The IR Act imposes a 1% excise tax on the fair market value of stock repurchases made by covered corporations after December 31, 2022. The total taxable value of shares repurchased is reduced by the fair market value of any newly issued shares during the taxable year. We are assessing the potential impact of the stock repurchase excise tax, but based on our preliminary assessment, we do not expect a material impact on our consolidated financial statements.

On August 9, 2022, the CHIPS and Science Act of 2022 (CHIPS Act) was enacted in the United States. The CHIPS Act will provide financial incentives to the semiconductor industry which are primarily directed at manufacturing activities within the United States. We are evaluating potential opportunities related to the CHIPS Act.
v3.22.2.2
Contingencies
9 Months Ended
Jul. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Contingencies Contingencies
Legal Proceedings
We are subject to routine legal proceedings, as well as demands, claims and threatened litigation that arise in the normal course of our business. The ultimate outcome of any litigation is often uncertain and unfavorable outcomes could have a negative impact on our results of operations and financial condition. We regularly review the status of each significant matter and assess our potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount is estimable, we accrue a liability for the estimated loss. Legal proceedings are inherently uncertain and, as circumstances change, it is possible that the amount of any accrued liability may increase, decrease or be eliminated.
We have determined that, except as set forth below, no disclosure of estimated loss is required for a claim against us because: (1) there is not a reasonable possibility that a loss exceeding amounts already recognized (if any) may be incurred with respect to such claim; (2) a reasonably possible loss or range of loss cannot be estimated; or (3) such estimate is immaterial.
Legal Settlement
There have been no changes to the disclosure related to Mentor Graphics Corporation (now part of Siemens AG) since our Annual Report. See Note 9. Contingencies of our Annual Report for further information.
Tax Matters
We undergo examination from time to time by U.S. and foreign authorities for non-income based taxes, such as sales, use and value-added taxes, and are currently under examination by tax authorities in certain jurisdictions. If
the potential loss from such examinations is considered probable and the amount or the range of loss could be estimated, we would accrue a liability for the estimated expense.
In addition to the foregoing, we are, from time to time, party to various other claims and legal proceedings in the ordinary course of our business, including with tax and other governmental authorities. For a description of certain of these other matters, see Note 18. Income Taxes.
v3.22.2.2
Summary of Significant Accounting Policies (Policies)
9 Months Ended
Jul. 31, 2022
Accounting Policies [Abstract]  
Use of Estimates Use of Estimates. To prepare financial statements in conformity with U.S. GAAP, management must make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Actual results could differ from these estimates and may result in material effects on our operating results and financial position.
Principles of Consolidation Principles of Consolidation. The unaudited condensed consolidated financial statements include our accounts and the accounts of our subsidiaries. All intercompany accounts and transactions have been eliminated.
Fiscal Year End Fiscal Year End. Our fiscal year generally ends on the Saturday nearest to October 31 and consists of 52 weeks, with the exception that approximately every five years, we have a 53-week year. When a 53-week year occurs, we include the additional week in the first quarter to realign fiscal quarters with calendar quarters. Fiscal 2022 and 2021 are both 52-week years. Fiscal 2022 will end on October 29, 2022. Fiscal 2021 ended on October 30, 2021. For presentation purposes, the unaudited condensed consolidated financial statements and accompanying notes refer to the closest calendar month end.
Redeemable Non-controlling Interest Redeemable Non-controlling Interest. Non-controlling interest that is not solely redeemable within our control is reported as the temporary equity in our unaudited condensed consolidated balance sheets. The carrying value of the redeemable non-controlling interest equals the redemption value at the end of each reporting period, after giving effect to the change from the net income (loss) attributable to the redeemable non-controlling interest. We adjust the redemption value of the non-controlling interest on a quarterly basis and changes in the estimated redemption value are recorded with corresponding adjustments against retained earnings.
Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Recently Adopted Accounting Pronouncements
In December 2019, the FASB issued Accounting Standards Update (ASU) 2019-12, Simplifying the Accounting for Income Taxes, which simplifies the accounting for income taxes, eliminates certain exceptions within ASC 740, Income Taxes, and clarifies certain aspects of the current guidance to promote consistency among reporting entities. We adopted the standard as of the beginning of fiscal 2022 on a prospective basis and the adoption of this standard did not have a material impact on our unaudited condensed consolidated financial statements.
In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The new guidance requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers, as if the acquirer had originated the contracts. We early adopted the standard in the second quarter of fiscal 2022 and the adoption had no material impact on our unaudited condensed consolidated financial statements for acquisitions completed in the first two quarters of fiscal 2022. The adoption of ASU 2021-08 resulted in the recognition of deferred revenue at amounts consistent with those recorded by the acquiree immediately before the acquisition date rather than at fair value for the business acquisition completed in the third quarter of fiscal 2022. See Note 4. Business Combinations for further information.
Recently Issued Accounting Pronouncements
In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (ASU 2022-03), which applies to all equity securities measured at fair value that are subject to contractual sale restrictions. This change prohibits entities from taking into account contractual restrictions on the sale of equity securities when estimating fair value and introduces required disclosures for such transactions. The standard will become effective for us beginning on November 1, 2024 and should be applied prospectively. Early adoption is permitted. The adoption of this guidance is not expected to have a material impact on our unaudited condensed consolidated financial statements.
v3.22.2.2
Revenue (Tables)
9 Months Ended
Jul. 31, 2022
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue The following table showed the percentage of revenue by product groups:
Three Months Ended 
 July 31,
Nine Months Ended 
 July 31,
2022202120222021
EDA50.0 %55.8 %49.9 %56.2 %
IP & System Integration39.7 %34.4 %40.7 %34.2 %
Software Integrity Products & Services9.5 %9.3 %8.9 %9.3 %
Other0.8 %0.5 %0.5 %0.3 %
Total100.0 %100.0 %100.0 %100.0 %
Schedule of Contract Assets and Liabilities Contract balances were as follows:
As of
July 31, 2022October 31, 2021
 (in thousands)
Contract assets, net$280,507 $284,574 
Unbilled receivables$41,863 $35,589 
Deferred revenue$1,920,558 $1,653,926 
v3.22.2.2
Business Combinations (Tables)
9 Months Ended
Jul. 31, 2022
Business Combinations [Abstract]  
Schedule of Preliminary Purchase Price Allocation
The aggregate purchase consideration was preliminarily allocated as follows:
(in thousands)
Total purchase consideration$330,112 
Less: cash acquired22,849 
Total purchase consideration, net of cash acquired$307,263 
Allocations
Goodwill$247,734 
Intangible assets97,500 
Deferred revenue(40,367)
Other tangible assets, net2,396 
$307,263 
v3.22.2.2
Goodwill and Intangible Assets (Tables)
9 Months Ended
Jul. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill The changes in the carrying amount of goodwill during the nine months ended July 31, 2022 were as follows:
 (in thousands)
Balance at October 31, 2021
$3,575,785 
Additions308,532 
Adjustments1,285 
Effect of foreign currency translation(30,713)
Balance at July 31, 2022
$3,854,889 
Summary of Intangible Assets
Intangible assets as of July 31, 2022 consisted of the following:
Gross Carrying AmountAccumulated
Amortization
Net Amount
 (in thousands)
Core/developed technology$1,078,103 $793,937 $284,166 
Customer relationships423,739 328,459 95,280 
Contract rights intangible191,430 188,524 2,906 
Trademarks and trade names52,795 33,157 19,638 
Capitalized software development costs48,068 45,406 2,662 
Total$1,794,135 $1,389,483 $404,652 
Intangible assets as of October 31, 2021 consisted of the following:
Gross Carrying AmountAccumulated
Amortization
Net Amount
 (in thousands)
Core/developed technology$911,903 $748,759 $163,144 
Customer relationships404,571 308,355 96,216 
Contract rights intangible193,317 188,231 5,086 
Trademarks and trade names43,095 31,155 11,940 
Capitalized software development costs46,098 43,352 2,746 
Total$1,598,984 $1,319,852 $279,132 
Amortization Expense Related to Intangible Assets
Amortization expense related to intangible assets consisted of the following:
 Three Months Ended 
 July 31,
Nine Months Ended 
 July 31,
 2022202120222021
 (in thousands)
Core/developed technology$18,603 $11,431 $45,180 $33,416 
Customer relationships6,322 7,960 20,819 23,443 
Contract rights intangible727 439 2,180 1,748 
Trademarks and trade names802 610 2,002 1,830 
Capitalized software development costs(1)
619 1,010 2,052 3,120 
Total$27,073 $21,450 $72,233 $63,557 
(1) Amortization of capitalized software development costs is included in cost of products revenue in the unaudited condensed consolidated statements of income.
Estimated Future Amortization of Intangible Assets The following table presented the estimated future amortization of intangible assets as of July 31, 2022:
Fiscal year(in thousands)
Remainder of fiscal 2022$26,960 
202398,039 
202486,748 
202570,102 
202657,677 
2027 and thereafter65,126 
Total$404,652 
v3.22.2.2
Balance Sheets Components (Tables)
9 Months Ended
Jul. 31, 2022
Balance Sheet Related Disclosures [Abstract]  
Schedule of Balance Sheets Components
As of
July 31, 2022October 31, 2021
(in thousands)
Other long-term assets:
Deferred compensation plan assets$295,415 $343,820 
Capitalized commission, net105,036 92,249 
Other long-term assets91,725 74,629 
Total$492,176 $510,698 
Accounts payable and accrued liabilities:
Payroll and related benefits$522,041 $581,687 
Other accrued liabilities142,060 132,091 
Accounts payable71,998 27,413 
Total$736,099 $741,191 
Other long-term liabilities:
Deferred compensation plan liabilities$295,413 $343,820 
Other long-term liabilities56,775 47,613 
Total$352,188 $391,433 
v3.22.2.2
Financial Assets and Liabilities (Tables)
9 Months Ended
Jul. 31, 2022
Financial Assets And Liabilities [Abstract]  
Debt Securities, Available-for-sale The stated maturities of our available-for-sale debt securities as of July 31, 2022 were as follows:
Amortized CostFair Value
(in thousands)
less than 1 year$72,253 $71,567 
1-5 years71,480 70,403 
5-10 years4,176 4,102 
>10 years1,610 1,527 
Total$149,519 $147,599 
Summary of Cash Equivalents and Short-Term Investments
As of July 31, 2022, the balances of our cash equivalents and short-term investments were as follows:
CostGross
Unrealized
Gains
Gross
Unrealized
Losses Less Than 12 Continuous Months
Gross
Unrealized
Losses 12 Continuous Months or Longer
Estimated
Fair Value
(1)
 (in thousands)
Cash equivalents:
Money market funds$94,796 $— $— $— $94,796 
Total:$94,796 $— $— $— $94,796 
Short-term investments:
U.S. government agency & T-bills$19,917 $$(117)$— $19,806 
Municipal bonds3,105 — (79)— 3,026 
Corporate debt securities98,318 30 (1,289)(108)96,951 
Asset-backed securities28,179 (328)(36)27,816 
Total:$149,519 $37 $(1,813)$(144)$147,599 
(1)See Note 8. Fair Value Measurements for further discussion on fair values of cash equivalents and short-term investments.
As of October 31, 2021, the balances of our cash equivalents and short-term investments were as follows:
CostGross
Unrealized
Gains
Gross
Unrealized
Losses Less Than 12 Continuous Months
Gross
Unrealized
Losses 12 Continuous Months or Longer
Estimated
Fair Value
(1)
 (in thousands)
Cash equivalents:
Money market funds$172,934 $— $— $— $172,934 
Total:$172,934 $— $— $— $172,934 
Short-term investments:
U.S. government agency & T-bills$6,447 $— $(5)$— $6,442 
Municipal bonds4,588 — (12)— 4,576 
Corporate debt securities103,615 (170)— 103,452 
Asset-backed securities33,545 (72)— 33,479 
Total:$148,195 $13 $(259)$— $147,949 
(1)See Note 8. Fair Value Measurements for further discussion on fair values of cash equivalents and short-term investments.
Schedule of Cash, Cash Equivalents and Restricted Cash The following table provided a reconciliation of cash, cash equivalents and restricted cash included in the unaudited condensed consolidated balance sheets:
As of
July 31, 2022October 31, 2021
(in thousands)
Cash and cash equivalents$1,383,559 $1,432,840 
Restricted cash included in prepaid and other current assets1,594 1,560 
Restricted cash included in other long-term assets711 783 
Total cash, cash equivalents and restricted cash$1,385,864 $1,435,183 
Effects on Changes in Fair Values of Non-Designated Forward Contracts
The effects of the non-designated derivative instruments on our unaudited condensed consolidated statements of income were summarized as follows:
 Three Months Ended 
 July 31,
Nine Months Ended 
 July 31,
 2022202120222021
 (in thousands)
Gains (losses) recorded in other income (expense), net$(5,182)$(837)$(10,443)$1,420 
Notional Amounts of Derivative Instruments
The notional amounts in the table below for derivative instruments provided one measure of the transaction volume outstanding:
As of
July 31, 2022October 31, 2021
 (in thousands)
Total gross notional amounts$1,295,726 $1,176,152 
Net fair value$(13,289)$13,404 
Fair Values of Derivative Instrument Designated and Non-Designated as Hedging Instruments in Balance Sheet
The following table represented the unaudited condensed consolidated balance sheets location and amount of derivative instrument fair values segregated between designated and non-designated hedge instruments:
Fair values of
derivative instruments
designated as hedging
instruments
Fair values of
derivative instruments
not designated as
hedging instruments
 (in thousands)
Balance at July 31, 2022
Other current assets$11,232 $1,510 
Accrued liabilities$25,975 $55 
Balance at October 31, 2021
Other current assets$15,455 $17 
Accrued liabilities$2,027 $42 
Income Statement Location and Amount of Gains and Losses on Derivative Instrument Fair Values for Designated Hedge Instruments, Net of Tax
The following table represented the location of the amount of gains and losses on derivative instrument fair values for designated hedge instruments, net of tax in the unaudited condensed consolidated statements of income:

Location of gains (losses) recognized in OCI on derivativesAmount of gains (losses) recognized in OCI on
derivatives
(effective portion)
Location of
gains (losses)
reclassified from OCI
Amount of
gains (losses)
reclassified from
OCI
(effective portion)
 (in thousands)
Three months ended 
 July 31, 2022
Foreign exchange contractsRevenue$(4,702)Revenue$3,651 
Foreign exchange contractsOperating expenses(14,349)Operating expenses(3,687)
Total$(19,051)$(36)
Three months ended 
 July 31, 2021
Foreign exchange contractsRevenue$251 Revenue$1,563 
Foreign exchange contractsOperating expenses3,413 Operating expenses3,267 
Total$3,664 $4,830 
Nine months ended 
 July 31, 2022
Foreign exchange contractsRevenue$(12,527)Revenue$3,309 
Foreign exchange contractsOperating expenses(29,242)Operating expenses(4,852)
Total$(41,769)$(1,543)
Nine months ended 
 July 31, 2021
Foreign exchange contractsRevenue$1,892 Revenue$2,597 
Foreign exchange contractsOperating expenses7,079 Operating expenses9,583 
Total$8,971 $12,180 
v3.22.2.2
Fair Value Measurements (Tables)
9 Months Ended
Jul. 31, 2022
Fair Value Disclosures [Abstract]  
Assets and Liabilities Measured at Fair Value on Recurring Basis
Assets and liabilities measured at fair value on a recurring basis were summarized below as of July 31, 2022:
  Fair Value Measurement Using
DescriptionTotalQuoted Prices in 
Active Markets
for Identical Assets
(Level 1)
Significant Other
Observable Inputs
(Level 2)
Significant
Unobservable
 Inputs
(Level 3)
 (in thousands)
Assets
Cash equivalents:
Money market funds$94,796 94,796 
Short-term investments:
U.S. government agency & T-bills19,806 19,806 
Municipal bonds3,026 3,026 
Corporate debt securities96,951 96,951 
Asset-backed securities27,816 27,816 
Prepaid and other current assets:
Foreign currency derivative contracts12,742 12,742 
Other long-term assets:
Deferred compensation plan assets295,415 295,415 
Total assets$550,552 $390,211 $160,341 $— 
Liabilities
Accounts payable and accrued liabilities:
Foreign currency derivative contracts$26,031 $26,031 
Other long-term liabilities:
Deferred compensation plan liabilities295,413 295,413 
Total liabilities$321,444 $295,413 $26,031 $— 
Assets and liabilities measured at fair value on a recurring basis were summarized below as of October 31, 2021:
  Fair Value Measurement Using
DescriptionTotalQuoted Prices in 
Active Markets
for Identical Assets
(Level 1)
Significant Other
Observable Inputs
(Level 2)
Significant
Unobservable 
Inputs
(Level 3)
 (in thousands)
Assets
Cash equivalents:
Money market funds$172,934 $172,934 
Short-term investments:
U.S. government agency & T-bills6,442 6,442 
Municipal bonds4,576 4,576 
Corporate debt securities103,452 103,452 
Asset-backed securities33,479 33,479 
Prepaid and other current assets:
Foreign currency derivative contracts15,472 15,472 
Other long-term assets:
Deferred compensation plan assets343,820 343,820 
Total assets$680,175 $516,754 $163,421 $— 
Liabilities
Accounts payable and accrued liabilities:
Foreign currency derivative contracts$2,068 $2,068 
Other long-term liabilities:
Deferred compensation plan liabilities343,820 343,820 
Total liabilities$345,888 $343,820 $2,068 $— 
v3.22.2.2
Leases (Tables)
9 Months Ended
Jul. 31, 2022
Leases [Abstract]  
Lease, Cost
The components of our lease expense during the period presented were as follows:
Three Months Ended July 31,Nine Months Ended July 31,
2022202120222021
(in thousands)
Operating lease expense (1)
$23,914 $23,843 $68,105 $70,818 
Variable lease expense (2)
2,910 2,184 7,904 5,361 
Total lease expense$26,824 $26,027 $76,009 $76,179 
(1) Operating lease expense includes immaterial amounts of short-term leases, net of sublease income.
(2) Variable lease expense includes payments to lessors that are not fixed or determinable at lease commencement date. These payments primarily consist of maintenance, property taxes, insurance and variable indexed based payments.
Supplemental cash flow information during the period presented was as follows:
Nine Months Ended July 31,
20222021
(in thousands)
Cash paid for amounts included in the measurement of operating lease liabilities$62,888 $64,516 
ROU assets obtained in exchange for operating lease liabilities$154,693 $92,149 
Lessee, Lease Term and Discount Rate Lease term and discount rate information related to our operating leases as of the end of the period presented were as follows:
As of
July 31, 2022October 31, 2021
Weighted-average remaining lease term (in years)9.328.00
Weighted-average discount rate2.18 %2.01 %
Lessee, Operating Lease, Liability, Maturity The following represented the maturities of our future lease payments due under operating leases as of July 31, 2022:
Lease Payments
Fiscal year(in thousands)
Remainder of fiscal 2022$18,637 
202367,100 
202490,806 
202580,162 
202670,782 
2027 and thereafter400,021 
Total future minimum lease payments
727,508 
Less: Imputed interest80,408 
Total lease liabilities
$647,100 
Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity The lease receipts from owned facilities, including sublease income from other facilities leased by us, due to us as of July 31, 2022 were as follows:
Lease Receipts
Fiscal year(in thousands)
Remainder of fiscal 2022$4,274 
202316,240 
202424,591 
202524,479 
202625,333 
2027 and thereafter110,189 
Total$205,106 
v3.22.2.2
Accumulated Other Comprehensive Income (Loss) (Tables)
9 Months Ended
Jul. 31, 2022
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
Components of Accumulated Other Comprehensive Income (Loss)
The components of accumulated other comprehensive income (loss), on an after-tax basis where applicable, were as follows:
As of
July 31, 2022October 31, 2021
 (in thousands)
Cumulative currency translation adjustments$(112,037)$(48,047)
Unrealized gains (losses) on derivative instruments, net of taxes(41,536)(1,311)
Unrealized gains (losses) on available-for-sale securities, net of taxes(1,920)(246)
Total$(155,493)$(49,604)
Effect of Amounts Reclassified out of Each Component of Accumulated Other Comprehensive Income (Loss) into Net Income
The effect of amounts reclassified out of each component of accumulated other comprehensive income (loss) into net income was as follows:
 Three Months Ended 
 July 31,
Nine Months Ended 
 July 31,
 2022202120222021
 (in thousands)
Reclassifications:
Gains (losses) on cash flow hedges, net of taxes
Revenues$3,651 $1,563 $3,309 $2,597 
Operating expenses(3,687)3,267 (4,852)9,583 
Total$(36)$4,830 $(1,543)$12,180 
v3.22.2.2
Stock Repurchase Program (Tables)
9 Months Ended
Jul. 31, 2022
Stock Repurchase Program [Abstract]  
Stock Repurchase And Reissuance Activities
Stock repurchase activities as well as the reissuance of treasury stock for employee stock-based compensation purposes were as follows:
 Three Months Ended 
 July 31,
Nine Months Ended 
 July 31,
 
2022 (1)
2021(2)
2022(1)
2021(2)
 (in thousands)
Total shares repurchased715 521 2,400 2,114 
Total cost of the repurchased shares$217,266 $140,000 $752,266 $538,082 
Reissuance of treasury stock764 564 2,342 2,093 
(1) Excluded the 101,821 shares and $40.0 million equity forward contract from the May 2022 ASR settled in August 2022.
(2) Excluded the 99,573 shares and $35.0 million equity forward contract from the June 2021 ASR settled in August 2021.
v3.22.2.2
Stock-Based Compensation (Tables)
9 Months Ended
Jul. 31, 2022
Share-based Payment Arrangement [Abstract]  
Stock Compensation Arrangements
The compensation cost recognized in the unaudited condensed consolidated statements of income for our stock compensation arrangements was as follows:
 Three Months Ended 
 July 31,
Nine Months Ended 
 July 31,
 2022202120222021
 (in thousands)
Cost of products$15,318 $9,582 $39,603 $28,238 
Cost of maintenance and service6,859 3,446 17,335 10,192 
Research and development expense68,243 42,430 175,892 124,231 
Sales and marketing expense22,998 15,330 60,090 45,040 
General and administrative expense14,187 14,374 40,517 40,829 
Stock-based compensation expense before taxes(1)
127,605 85,162 333,437 248,530 
Income tax benefit(20,940)(13,277)(54,717)(38,746)
Stock-based compensation expense after taxes$106,665 $71,885 $278,720 $209,784 
(1) During the three and nine months ended July 31, 2022, we recognized stock-based compensation expense relating to restricted stock units (RSUs), granted to senior executives in February 2022 with certain market, performance and service conditions (market-based RSUs). Under the award agreements, the vesting of the market-based RSUs is contingent on achieving total stockholder return (TSR) relative to a peer index as well as revenue growth metrics. The performance period during which the achievement goals will be measured is fiscal 2022 and fiscal 2023. The maximum potential awards that may be earned are 187.5% of the target number of the initial awards. The awards will vest in equal increments in December 2023 and December 2024 if the TSR target, revenue growth metrics, and service conditions are achieved. The grant date fair value for the market-based RSUs of $280.82 was determined using a Monte Carlo simulation model with the following assumptions: expected volatility of 33.01%, risk-free interest rate of 1.33% and an expected term of 1.69 years.
Schedule of Intrinsic Value of Equity Awards Exercised
The intrinsic values of equity awards exercised during the periods were as follows:
 Three Months Ended 
 July 31,
Nine Months Ended 
 July 31,
 2022202120222021
 (in thousands)
Intrinsic value of awards exercised$86,080 $30,896 $245,468 $143,100 
v3.22.2.2
Net Income per Share (Tables)
9 Months Ended
Jul. 31, 2022
Earnings Per Share [Abstract]  
Reconciliation of Weighted-Average Common Shares Used to Calculate Net Income Per Share
The table below reconciled the weighted average common shares used to calculate basic net income per share with the weighted average common shares used to calculate diluted net income per share:
 Three Months Ended 
 July 31,
Nine Months Ended 
 July 31,
 2022202120222021
 (in thousands, except per share amounts)
Numerator:
Net income attributed to Synopsys$222,626 $198,646 $831,094 $556,069 
Denominator:
Weighted average common shares for basic net income per share152,938 152,635 153,082 152,619 
Dilutive effect of common share equivalents2,868 4,272 3,463 4,539 
Weighted average common shares for diluted net income per share155,806 156,907 156,545 157,158 
Net income per share attributed to Synopsys:
Basic$1.46 $1.30 $5.43 $3.64 
Diluted$1.43 $1.27 $5.31 $3.54 
Anti-dilutive employee stock-based awards excluded336 355 268 405 
v3.22.2.2
Segment Disclosure (Tables)
9 Months Ended
Jul. 31, 2022
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information Information by reportable segment was as follows:
 Three Months Ended 
 July 31,
Nine Months Ended 
 July 31,
 2022202120222021
 (in thousands)
Total Segments:
Revenue$1,247,766 $1,057,130 $3,797,250 $3,051,774 
Adjusted operating income392,127 337,396 1,321,671 941,456 
Adjusted operating margin31 %32 %35 %31 %
Semiconductor & System Design:
Revenue$1,129,427 $959,155 $3,458,499 $2,767,950 
Adjusted operating income380,871 328,742 1,285,391 916,434 
Adjusted operating margin34 %34 %37 %33 %
Software Integrity:
Revenue$118,339 $97,975 $338,751 $283,824 
Adjusted operating income11,256 8,654 36,280 25,022 
Adjusted operating margin10 %%11 %%
Reconciliation of Operating Income From Segment Consolidation The unallocated expenses managed at a consolidated level, including amortization of intangible assets, stock-based compensation and certain other operating expenses, were presented in the table below to provide a reconciliation of the total adjusted operating income from segments to our consolidated operating income:
 Three Months Ended 
 July 31,
Nine Months Ended 
 July 31,
 2022202120222021
 (in thousands)
Total segment adjusted operating income$392,127 $337,396 $1,321,671 $941,456 
Reconciling items:
Amortization of intangible assets(26,454)(20,440)(70,181)(60,437)
Stock-based compensation expense(127,605)(85,162)(333,437)(248,530)
Other(4,140)(29,871)26,612 (87,987)
Total operating income$233,928 $201,923 $944,665 $544,502 
Revenues Related to Operations by Geographic Areas Revenue related to operations in the United States and other geographic areas were: 
 Three Months Ended 
 July 31,
Nine Months Ended 
 July 31,
 2022202120222021
 (in thousands)
Revenue:
United States$575,326 $477,218 $1,763,541 $1,417,636 
Europe127,288 112,877 376,195 324,212 
China189,138 164,172 617,524 405,460 
Korea125,307 110,536 358,871 314,178 
Other230,707 192,327 681,119 590,288 
Consolidated$1,247,766 $1,057,130 $3,797,250 $3,051,774 
v3.22.2.2
Other Income (Expense), Net (Tables)
9 Months Ended
Jul. 31, 2022
Other Income and Expenses [Abstract]  
Components of Other Income (Expense), Net
The following table presented the components of other income (expense), net:
 Three Months Ended 
 July 31,
Nine Months Ended 
 July 31,
 2022202120222021
 (in thousands)
Interest income$2,735 $657 $4,876 $1,413 
Interest expense(439)(757)(1,339)(2,301)
Gains (losses) on assets related to deferred compensation plan(1,092)10,473 (50,001)62,697 
Foreign currency exchange gains (losses)(376)2,756 3,452 5,283 
Other, net1,598 (1,715)1,732 (5,158)
Total$2,426 $11,414 $(41,280)$61,934 
v3.22.2.2
Income Taxes (Tables)
9 Months Ended
Jul. 31, 2022
Income Tax Disclosure [Abstract]  
Provision (Benefit) for Incomes Taxes and Effective Tax Rates
The following table presented the provision for income taxes and the effective tax rates:
 Three Months Ended 
 July 31,
Nine Months Ended 
 July 31,
 2022202120222021
 (in thousands)
Income before income taxes$236,354 $213,337 $903,385 $606,436 
Provision for income taxes$16,708 $14,945 $76,506 $51,214 
Effective tax rate7.1 %7.0 %8.5 %8.4 %
v3.22.2.2
Revenue - Schedule of Disaggregation of Revenue (Details) - Product Concentration Risk - Revenue
3 Months Ended 9 Months Ended
Jul. 31, 2022
Jul. 31, 2021
Jul. 31, 2022
Jul. 31, 2021
Disaggregation of Revenue [Line Items]        
Revenue percentage by product group 100.00% 100.00% 100.00% 100.00%
EDA        
Disaggregation of Revenue [Line Items]        
Revenue percentage by product group 50.00% 55.80% 49.90% 56.20%
IP & System Integration        
Disaggregation of Revenue [Line Items]        
Revenue percentage by product group 39.70% 34.40% 40.70% 34.20%
Software Integrity Products & Services        
Disaggregation of Revenue [Line Items]        
Revenue percentage by product group 9.50% 9.30% 8.90% 9.30%
Other        
Disaggregation of Revenue [Line Items]        
Revenue percentage by product group 0.80% 0.50% 0.50% 0.30%
v3.22.2.2
Revenue - Schedule of Contract Assets and Liabilities (Details) - USD ($)
$ in Thousands
Jul. 31, 2022
Oct. 31, 2021
Revenue from Contract with Customer [Abstract]    
Contract assets, net $ 280,507 $ 284,574
Unbilled receivables 41,863 35,589
Deferred revenue $ 1,920,558 $ 1,653,926
v3.22.2.2
Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jul. 31, 2022
Jul. 31, 2021
Jul. 31, 2022
Jul. 31, 2021
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]        
Contract with customer, liability, revenue recognized $ 171,200   $ 1,100,000  
Revenue, remaining performance obligation, amount 7,100,000   7,100,000  
Revenue, remaining performance obligation, non-cancellable, amount $ 998,100   $ 998,100  
Revenue, remaining performance obligation, excluding non-cancellable, recognized over twelve month period, percent 42.00%   42.00%  
Capitalized contract cost, net $ 105,000   $ 105,000  
Amortization of capitalized costs to obtain revenue contracts 19,900 $ 16,500 54,438 $ 46,973
Sales Based Royalties        
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]        
Contract with customer, liability, revenue recognized $ 33,900 $ 27,900 $ 103,500 $ 88,700
v3.22.2.2
Business Combinations - Additional Information (Details) - USD ($)
3 Months Ended 9 Months Ended
Jun. 22, 2022
Jul. 31, 2022
Apr. 30, 2022
Jan. 31, 2022
Jul. 31, 2021
Jul. 31, 2022
Jul. 31, 2021
Oct. 31, 2021
Business Acquisition [Line Items]                
Goodwill   $ 3,854,889,000       $ 3,854,889,000   $ 3,575,785,000
Redeemable non-controlling interest   43,516,000       43,516,000   $ 0
Transaction costs   5,200,000     $ 5,700,000 11,300,000 $ 11,600,000  
NTT Security AppSec Solutions Inc                
Business Acquisition [Line Items]                
Cash paid $ 330,112,000              
Goodwill 247,734,000              
Goodwill, expected tax deductible amount 0              
Intangible assets 97,500,000              
Consideration transfered $ 307,263,000              
NTT Security AppSec Solutions Inc | Minimum                
Business Acquisition [Line Items]                
Acquired finite-lived intangible assets, weighted average useful life 5 years              
NTT Security AppSec Solutions Inc | Maximum                
Business Acquisition [Line Items]                
Acquired finite-lived intangible assets, weighted average useful life 10 years              
Series of Individually Immaterial Business Acquisitions                
Business Acquisition [Line Items]                
Goodwill       $ 15,700,000        
Goodwill, expected tax deductible amount       0        
Intangible assets       4,300,000        
Consideration transfered       $ 20,000,000        
OpenLight                
Business Acquisition [Line Items]                
Goodwill     $ 45,100,000          
Goodwill, expected tax deductible amount     0          
Intangible assets     94,000,000          
Consideration transfered     $ 90,000,000          
Percentage of equity interests acquired     75.00%          
Percentage of equity interests held by non-controlling interest     25.00%          
Redeemable noncontrolling interest, redemption value     $ 30,000,000          
Redeemable noncontrolling interest, put option value     10,100,000          
Consideration transferred including redeemable noncontrolling interest     $ 100,100,000          
Net income (loss) incurred by OpenLight   12,900,000            
Net income (loss), attributable to redeemable non-controlling interest   3,200,000            
Redeemable non-controlling interest   $ 43,500,000       $ 43,500,000    
v3.22.2.2
Business Combinations - Schedule of Acquisition Purchase Price (Details) - USD ($)
$ in Thousands
Jun. 22, 2022
Jul. 31, 2022
Oct. 31, 2021
Business Acquisition [Line Items]      
Goodwill   $ 3,854,889 $ 3,575,785
NTT Security AppSec Solutions Inc      
Business Acquisition [Line Items]      
Total purchase consideration $ 330,112    
Less: cash acquired 22,849    
Total consideration 307,263    
Goodwill 247,734    
Intangible assets 97,500    
Deferred revenue (40,367)    
Other tangible assets, net 2,396    
Total purchase allocation $ 307,263    
v3.22.2.2
Goodwill and Intangible Assets - Changes of Goodwill (Details)
$ in Thousands
9 Months Ended
Jul. 31, 2022
USD ($)
Goodwill [Roll Forward]  
Beginning Balance $ 3,575,785
Additions 308,532
Adjustments 1,285
Effect of foreign currency translation (30,713)
Ending Balance $ 3,854,889
v3.22.2.2
Goodwill and Intangible Assets - Summary of Intangible Assets (Detail) - USD ($)
$ in Thousands
Jul. 31, 2022
Oct. 31, 2021
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 1,794,135 $ 1,598,984
Accumulated Amortization 1,389,483 1,319,852
Net Amount 404,652 279,132
Core/developed technology    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 1,078,103 911,903
Accumulated Amortization 793,937 748,759
Net Amount 284,166 163,144
Customer relationships    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 423,739 404,571
Accumulated Amortization 328,459 308,355
Net Amount 95,280 96,216
Contract rights intangible    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 191,430 193,317
Accumulated Amortization 188,524 188,231
Net Amount 2,906 5,086
Trademarks and trade names    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 52,795 43,095
Accumulated Amortization 33,157 31,155
Net Amount 19,638 11,940
Capitalized software development costs    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 48,068 46,098
Accumulated Amortization 45,406 43,352
Net Amount $ 2,662 $ 2,746
v3.22.2.2
Goodwill and Intangible Assets - Amortization Expense Related to Intangible Assets (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jul. 31, 2022
Jul. 31, 2021
Jul. 31, 2022
Jul. 31, 2021
Finite Lived Intangible Assets Amortization Expense [Line Items]        
Amortization expense of intangible assets $ 27,073 $ 21,450 $ 72,233 $ 63,557
Core/developed technology        
Finite Lived Intangible Assets Amortization Expense [Line Items]        
Amortization expense of intangible assets 18,603 11,431 45,180 33,416
Customer relationships        
Finite Lived Intangible Assets Amortization Expense [Line Items]        
Amortization expense of intangible assets 6,322 7,960 20,819 23,443
Contract rights intangible        
Finite Lived Intangible Assets Amortization Expense [Line Items]        
Amortization expense of intangible assets 727 439 2,180 1,748
Trademarks and trade names        
Finite Lived Intangible Assets Amortization Expense [Line Items]        
Amortization expense of intangible assets 802 610 2,002 1,830
Capitalized software development costs        
Finite Lived Intangible Assets Amortization Expense [Line Items]        
Amortization expense of intangible assets [1] $ 619 $ 1,010 $ 2,052 $ 3,120
[1] Amortization of capitalized software development costs is included in cost of products revenue in the unaudited condensed consolidated statements of income.
v3.22.2.2
Goodwill and Intangible Assets - Estimated Future Amortization of Intangible Assets (Detail)
$ in Thousands
Jul. 31, 2022
USD ($)
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]  
Remainder of fiscal 2022 $ 26,960
2023 98,039
2024 86,748
2025 70,102
2026 57,677
2027 and thereafter 65,126
Total $ 404,652
v3.22.2.2
Balance Sheets Components - Components of Balance Sheet (Details) - USD ($)
$ in Thousands
Jul. 31, 2022
Oct. 31, 2021
Other long-term assets:    
Deferred compensation plan assets $ 295,415 $ 343,820
Capitalized commission, net 105,036 92,249
Other long-term assets 91,725 74,629
Total 492,176 510,698
Accounts payable and accrued liabilities:    
Payroll and related benefits 522,041 581,687
Other accrued liabilities 142,060 132,091
Accounts payable 71,998 27,413
Total 736,099 741,191
Other long-term liabilities:    
Deferred compensation plan liabilities 295,413 343,820
Other long-term liabilities 56,775 47,613
Total $ 352,188 $ 391,433
v3.22.2.2
Financial Assets and Liabilities - Additional Information (Details) - USD ($)
3 Months Ended 9 Months Ended
Jul. 31, 2022
Jul. 31, 2021
Jul. 31, 2022
Jul. 31, 2021
Financial Assets and Liabilities [Line Items]        
Impairment of non-marketable equity securities $ 0 $ 0 $ 0 $ 0
Shipments period using hedges (in months)     1 month  
Period for hedge balance in OCI to be reclassified to statement of operations (in months)     12 months  
Non-Designated Hedging Instrument        
Financial Assets and Liabilities [Line Items]        
Forward contracts terms (in months)     1 month  
Foreign currency derivative contracts | Minimum        
Financial Assets and Liabilities [Line Items]        
Derivative maturity period     1 month  
Foreign currency derivative contracts | Maximum        
Financial Assets and Liabilities [Line Items]        
Derivative maturity period     27 months  
Foreign currency derivative contracts | Cash Flow Hedging | Maximum        
Financial Assets and Liabilities [Line Items]        
Derivative maturity period     3 years  
Foreign Exchange Forward | Cash Flow Hedging | Maximum        
Financial Assets and Liabilities [Line Items]        
Derivative maturity period     27 months  
Foreign Exchange Contracts | Non-Designated Hedging Instrument | Maximum        
Financial Assets and Liabilities [Line Items]        
Non-designated foreign exchange forward contract remaining maturity     1 year  
v3.22.2.2
Financial Assets and Liabilities - Schedule of Maturity for Short-Term Available for Sale Securities (Details) - USD ($)
$ in Thousands
Jul. 31, 2022
Oct. 31, 2021
Amortized Cost    
less than 1 year $ 72,253  
1-5 years 71,480  
5-10 years 4,176  
>10 years 1,610  
Total 149,519 $ 148,195
Fair Value    
less than 1 year 71,567  
1-5 years 70,403  
5-10 years 4,102  
>10 years 1,527  
Total $ 147,599 [1] $ 147,949 [2]
[1] See Note 8. Fair Value Measurements for further discussion on fair values of cash equivalents and short-term investments.
[2] See Note 8. Fair Value Measurements for further discussion on fair values of cash equivalents and short-term investments.
v3.22.2.2
Financial Assets and Liabilities - Short-term investments (Details) - USD ($)
$ in Thousands
Jul. 31, 2022
Oct. 31, 2021
Cash Equivalents and Short-term Investments [Line Items]    
Total $ 149,519 $ 148,195
Gross Unrealized Gains 37 13
Gross Unrealized Losses Less Than 12 Continuous Months (1,813) (259)
Gross Unrealized Losses 12 Continuous Months or Longer (144) 0
Estimated fair value 147,599 [1] 147,949 [2]
Cash equivalents    
Cash Equivalents and Short-term Investments [Line Items]    
Total 94,796 172,934
Gross Unrealized Gains 0 0
Gross Unrealized Losses Less Than 12 Continuous Months 0 0
Gross Unrealized Losses 12 Continuous Months or Longer 0 0
Estimated fair value 94,796 [1] 172,934 [2]
Cash equivalents | Money market funds    
Cash Equivalents and Short-term Investments [Line Items]    
Total 94,796 172,934
Gross Unrealized Gains 0 0
Gross Unrealized Losses Less Than 12 Continuous Months 0 0
Gross Unrealized Losses 12 Continuous Months or Longer 0 0
Estimated fair value 94,796 [1] 172,934 [2]
Short-term investments | Corporate debt securities    
Cash Equivalents and Short-term Investments [Line Items]    
Total 98,318 103,615
Gross Unrealized Gains 30 7
Gross Unrealized Losses Less Than 12 Continuous Months (1,289) (170)
Gross Unrealized Losses 12 Continuous Months or Longer (108) 0
Estimated fair value 96,951 [1] 103,452 [2]
Short-term investments | U.S. government agency & T-bills    
Cash Equivalents and Short-term Investments [Line Items]    
Total 19,917 6,447
Gross Unrealized Gains 6 0
Gross Unrealized Losses Less Than 12 Continuous Months (117) (5)
Gross Unrealized Losses 12 Continuous Months or Longer 0 0
Estimated fair value 19,806 [1] 6,442 [2]
Short-term investments | Municipal bonds    
Cash Equivalents and Short-term Investments [Line Items]    
Total 3,105 4,588
Gross Unrealized Gains 0 0
Gross Unrealized Losses Less Than 12 Continuous Months (79) (12)
Gross Unrealized Losses 12 Continuous Months or Longer 0 0
Estimated fair value 3,026 [1] 4,576 [2]
Short-term investments | Asset-backed securities    
Cash Equivalents and Short-term Investments [Line Items]    
Total 28,179 33,545
Gross Unrealized Gains 1 6
Gross Unrealized Losses Less Than 12 Continuous Months (328) (72)
Gross Unrealized Losses 12 Continuous Months or Longer (36) 0
Estimated fair value $ 27,816 [1] $ 33,479 [2]
[1] See Note 8. Fair Value Measurements for further discussion on fair values of cash equivalents and short-term investments.
[2] See Note 8. Fair Value Measurements for further discussion on fair values of cash equivalents and short-term investments.
v3.22.2.2
Financial Assets and Liabilities - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)
$ in Thousands
Jul. 31, 2022
Oct. 31, 2021
Jul. 31, 2021
Oct. 31, 2020
Cash and Cash Equivalents [Line Items]        
Cash and cash equivalents $ 1,383,559 $ 1,432,840    
Total cash, cash equivalents and restricted cash 1,385,864 1,435,183 $ 1,387,737 $ 1,237,970
Restricted cash included in prepaid and other current assets        
Cash and Cash Equivalents [Line Items]        
Restricted cash 1,594 1,560    
Restricted cash included in other long-term assets        
Cash and Cash Equivalents [Line Items]        
Restricted cash $ 711 $ 783    
v3.22.2.2
Financial Assets and Liabilities - Effects on Changes in Fair Values of Non-Designated Forward Contracts (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jul. 31, 2022
Jul. 31, 2021
Jul. 31, 2022
Jul. 31, 2021
Financial Assets And Liabilities [Abstract]        
Gains (losses) recorded in other income (expense), net $ (5,182) $ (837) $ (10,443) $ 1,420
v3.22.2.2
Financial Assets and Liabilities - Notional Amounts of Derivative Instruments (Detail) - USD ($)
$ in Thousands
Jul. 31, 2022
Oct. 31, 2021
Financial Assets And Liabilities [Abstract]    
Total gross notional amounts $ 1,295,726 $ 1,176,152
Net fair value $ (13,289) $ 13,404
v3.22.2.2
Financial Assets and Liabilities - Fair Values of Derivative Instrument Designated and Non-Designated as Hedging Instruments in Unaudited Condensed Consolidated Balance Sheet (Detail) - USD ($)
$ in Thousands
Jul. 31, 2022
Oct. 31, 2021
Designated As Hedging Instrument | Other current assets    
Financial Assets and Liabilities [Line Items]    
Fair values of derivative instruments, assets $ 11,232 $ 15,455
Designated As Hedging Instrument | Accrued liabilities    
Financial Assets and Liabilities [Line Items]    
Fair values of derivative instruments, liabilities 25,975 2,027
Non-Designated Hedging Instrument | Other current assets    
Financial Assets and Liabilities [Line Items]    
Fair values of derivative instruments, assets 1,510 17
Non-Designated Hedging Instrument | Accrued liabilities    
Financial Assets and Liabilities [Line Items]    
Fair values of derivative instruments, liabilities $ 55 $ 42
v3.22.2.2
Financial Assets and Liabilities - Unaudited Condensed Consolidated Statement of Operations Location and Amount of Gains and Losses on Derivative Instrument Fair Values for Designated Hedge Instruments, Net of Tax (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jul. 31, 2022
Jul. 31, 2021
Jul. 31, 2022
Jul. 31, 2021
Financial Assets and Liabilities [Line Items]        
Total revenue $ 1,247,766 $ 1,057,130 $ 3,797,250 $ 3,051,774
Operating Expenses 742,657 650,141 2,071,609 1,880,221
Net income 222,626 198,646 831,094 556,069
Foreign Exchange Contracts | Amount of gains (losses) recognized in OCI on derivatives (effective portion)        
Financial Assets and Liabilities [Line Items]        
Total revenue (4,702) 251 (12,527) 1,892
Operating Expenses (14,349) 3,413 (29,242) 7,079
Net income (19,051) 3,664 (41,769) 8,971
Foreign Exchange Contracts | Amount of gains (losses) reclassified from OCI (effective portion)        
Financial Assets and Liabilities [Line Items]        
Total revenue 3,651 1,563 3,309 2,597
Operating Expenses (3,687) 3,267 (4,852) 9,583
Net income $ (36) $ 4,830 $ (1,543) $ 12,180
v3.22.2.2
Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - Fair Value, Measurements, Recurring - USD ($)
$ in Thousands
Jul. 31, 2022
Oct. 31, 2021
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Total assets $ 550,552 $ 680,175
Total liabilities 321,444 345,888
Deferred compensation plan liabilities    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Other long-term liabilities 295,413 343,820
Foreign currency derivative contracts    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Prepaid and other current assets 12,742 15,472
Accounts payable and accrued liabilities 26,031 2,068
Cash equivalents | Money market funds    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Cash equivalents 94,796 172,934
Short-term investments | U.S. government agency & T-bills    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Short-term investments 19,806 6,442
Short-term investments | Municipal bonds    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Short-term investments 3,026 4,576
Short-term investments | Corporate debt securities    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Short-term investments 96,951 103,452
Short-term investments | Asset-backed securities    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Short-term investments 27,816 33,479
Deferred compensation plan assets    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Other long-term assets 295,415 343,820
Quoted Prices in  Active Markets for Identical Assets (Level 1)    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Total assets 390,211 516,754
Total liabilities 295,413 343,820
Quoted Prices in  Active Markets for Identical Assets (Level 1) | Deferred compensation plan liabilities    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Other long-term liabilities 295,413 343,820
Quoted Prices in  Active Markets for Identical Assets (Level 1) | Foreign currency derivative contracts    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Prepaid and other current assets
Accounts payable and accrued liabilities
Quoted Prices in  Active Markets for Identical Assets (Level 1) | Cash equivalents | Money market funds    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Cash equivalents 94,796 172,934
Quoted Prices in  Active Markets for Identical Assets (Level 1) | Short-term investments | U.S. government agency & T-bills    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Short-term investments
Quoted Prices in  Active Markets for Identical Assets (Level 1) | Short-term investments | Municipal bonds    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Short-term investments
Quoted Prices in  Active Markets for Identical Assets (Level 1) | Short-term investments | Corporate debt securities    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Short-term investments
Quoted Prices in  Active Markets for Identical Assets (Level 1) | Short-term investments | Asset-backed securities    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Short-term investments
Quoted Prices in  Active Markets for Identical Assets (Level 1) | Deferred compensation plan assets    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Other long-term assets 295,415 343,820
Significant Other Observable Inputs (Level 2)    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Total assets 160,341 163,421
Total liabilities 26,031 2,068
Significant Other Observable Inputs (Level 2) | Deferred compensation plan liabilities    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Other long-term liabilities
Significant Other Observable Inputs (Level 2) | Foreign currency derivative contracts    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Prepaid and other current assets 12,742 15,472
Accounts payable and accrued liabilities 26,031 2,068
Significant Other Observable Inputs (Level 2) | Cash equivalents | Money market funds    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Cash equivalents
Significant Other Observable Inputs (Level 2) | Short-term investments | U.S. government agency & T-bills    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Short-term investments 19,806 6,442
Significant Other Observable Inputs (Level 2) | Short-term investments | Municipal bonds    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Short-term investments 3,026 4,576
Significant Other Observable Inputs (Level 2) | Short-term investments | Corporate debt securities    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Short-term investments 96,951 103,452
Significant Other Observable Inputs (Level 2) | Short-term investments | Asset-backed securities    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Short-term investments 27,816 33,479
Significant Other Observable Inputs (Level 2) | Deferred compensation plan assets    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Other long-term assets
Significant Unobservable  Inputs (Level 3)    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Total assets 0 0
Total liabilities 0 0
Significant Unobservable  Inputs (Level 3) | Deferred compensation plan liabilities    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Other long-term liabilities
Significant Unobservable  Inputs (Level 3) | Foreign currency derivative contracts    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Prepaid and other current assets
Accounts payable and accrued liabilities
Significant Unobservable  Inputs (Level 3) | Cash equivalents | Money market funds    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Cash equivalents
Significant Unobservable  Inputs (Level 3) | Short-term investments | U.S. government agency & T-bills    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Short-term investments
Significant Unobservable  Inputs (Level 3) | Short-term investments | Municipal bonds    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Short-term investments
Significant Unobservable  Inputs (Level 3) | Short-term investments | Corporate debt securities    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Short-term investments
Significant Unobservable  Inputs (Level 3) | Short-term investments | Asset-backed securities    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Short-term investments
Significant Unobservable  Inputs (Level 3) | Deferred compensation plan assets    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Other long-term assets
v3.22.2.2
Restructuring Charges - Additional Information (Details) - 2021 Restructuring Plan - Severance and Termination
$ in Millions
3 Months Ended
Jul. 31, 2022
USD ($)
Restructuring Cost and Reserve [Line Items]  
Restructuring and Related Cost, Cost Incurred to Date $ 45.5
Cash payments $ 0.9
v3.22.2.2
Credit and Term Loan Facilities - Additional Information (Detail)
¥ in Millions, $ in Millions
1 Months Ended 9 Months Ended
Jul. 31, 2018
USD ($)
Jul. 31, 2022
USD ($)
Oct. 31, 2021
USD ($)
Jan. 22, 2021
USD ($)
Jul. 31, 2018
CNY (¥)
Foreign Line of Credit          
Debt Instrument [Line Items]          
Credit facility maximum borrowing capacity $ 33.0       ¥ 220.0
Borrowings, interest rate 0.74%        
Debt instrument, term 12 years        
Long-term line of credit, noncurrent   $ 22.0      
Fourth Amendment | Unsecured Debt | Term Loan          
Debt Instrument [Line Items]          
Credit facility borrowing capacity       $ 97.5  
Fourth Amendment | Unsecured Debt | Senior Revolving Credit Facility          
Debt Instrument [Line Items]          
Credit facility maximum borrowing capacity       650.0  
Fourth Amendment | Unsecured Debt | Uncommitted Incremental Loan Facility          
Debt Instrument [Line Items]          
Credit facility maximum borrowing capacity       $ 150.0  
The Credit Agreement | Unsecured Debt | Revolving Credit Facility          
Debt Instrument [Line Items]          
Current portion of line of credit   $ 0.0 $ 0.0    
The Credit Agreement | Unsecured Debt | Revolving Credit Facility | Minimum          
Debt Instrument [Line Items]          
Commitment fees percentage   0.125%      
The Credit Agreement | Unsecured Debt | Revolving Credit Facility | Maximum          
Debt Instrument [Line Items]          
Commitment fees percentage   0.20%      
The Credit Agreement | Unsecured Debt | Revolving Credit Facility | London Interbank Offered Rate (LIBOR)          
Debt Instrument [Line Items]          
Borrowings, interest rate   1.00%      
v3.22.2.2
Leases (Details)
Jul. 31, 2022
Maximum  
Lessee, Lease, Description [Line Items]  
Lessee, operating lease, renewal term 10 years
v3.22.2.2
Leases - Components Of Lease Expense (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jul. 31, 2022
Jul. 31, 2021
Jul. 31, 2022
Jul. 31, 2021
Leases [Abstract]        
Operating lease expense [1] $ 23,914 $ 23,843 $ 68,105 $ 70,818
Variable lease expense [2] 2,910 2,184 7,904 5,361
Total lease expense $ 26,824 $ 26,027 $ 76,009 $ 76,179
[1] Operating lease expense includes immaterial amounts of short-term leases, net of sublease income.
[2] Variable lease expense includes payments to lessors that are not fixed or determinable at lease commencement date. These payments primarily consist of maintenance, property taxes, insurance and variable indexed based payments.
v3.22.2.2
Leases - Supplemental Cash Flow Information (Details) - USD ($)
$ in Thousands
9 Months Ended
Jul. 31, 2022
Jul. 31, 2021
Leases [Abstract]    
Cash paid for amounts included in the measurement of operating lease liabilities $ 62,888 $ 64,516
ROU assets obtained in exchange for operating lease liabilities $ 154,693 $ 92,149
v3.22.2.2
Leases - Lease Term And Discount Rate Information (Details)
Jul. 31, 2022
Oct. 31, 2021
Leases [Abstract]    
Weighted-average remaining lease term (in years) 9 years 3 months 25 days 8 years
Weighted-average discount rate 2.18% 2.01%
v3.22.2.2
Leases - Future Minimum Payments (Details)
$ in Thousands
Jul. 31, 2022
USD ($)
Leases [Abstract]  
Remainder of fiscal 2022 $ 18,637
2023 67,100
2024 90,806
2025 80,162
2026 70,782
2027 and thereafter 400,021
Total future minimum lease payments 727,508
Less: Imputed interest 80,408
Total lease liabilities $ 647,100
v3.22.2.2
Leases - Lease Receipts (Details)
$ in Thousands
Jul. 31, 2022
USD ($)
Leases [Abstract]  
Remainder of fiscal 2022 $ 4,274
2023 16,240
2024 24,591
2025 24,479
2026 25,333
2027 and thereafter 110,189
Total $ 205,106
v3.22.2.2
Accumulated Other Comprehensive Income (Loss) - Components of Accumulated Other Comprehensive Income (Loss) (Detail) - USD ($)
$ in Thousands
Jul. 31, 2022
Oct. 31, 2021
Reclassification Adjustment Balance In Accumulated Other Comprehensive Income [Line Items]    
Accumulated other comprehensive income (loss) $ (155,493) $ (49,604)
Cumulative currency translation adjustments    
Reclassification Adjustment Balance In Accumulated Other Comprehensive Income [Line Items]    
Accumulated other comprehensive income (loss) (112,037) (48,047)
Unrealized gains (losses) on derivative instruments, net of taxes    
Reclassification Adjustment Balance In Accumulated Other Comprehensive Income [Line Items]    
Accumulated other comprehensive income (loss) (41,536) (1,311)
Unrealized gains (losses) on available-for-sale securities, net of taxes    
Reclassification Adjustment Balance In Accumulated Other Comprehensive Income [Line Items]    
Accumulated other comprehensive income (loss) $ (1,920) $ (246)
v3.22.2.2
Accumulated Other Comprehensive Income (Loss) - Effect of Amounts Reclassified out of Each Component of Accumulated Other Comprehensive Income (Loss) into Net Income (Detail) - Reclassification out of accumulated other comprehensive income (loss) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jul. 31, 2022
Jul. 31, 2021
Jul. 31, 2022
Jul. 31, 2021
Reclassification Adjustment Balance In Accumulated Other Comprehensive Income [Line Items]        
Reclassifications into net income $ (36) $ 4,830 $ (1,543) $ 12,180
Revenues | Gain (loss) on cash flow hedges, net of taxes        
Reclassification Adjustment Balance In Accumulated Other Comprehensive Income [Line Items]        
Reclassifications into net income 3,651 1,563 3,309 2,597
Operating expenses | Gain (loss) on cash flow hedges, net of taxes        
Reclassification Adjustment Balance In Accumulated Other Comprehensive Income [Line Items]        
Reclassifications into net income $ (3,687) $ 3,267 $ (4,852) $ 9,583
v3.22.2.2
Stock Repurchase Program - Additional Information (Detail) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 31, 2022
May 31, 2022
Jul. 31, 2022
Jul. 31, 2021
[2]
Jul. 31, 2022
Jul. 31, 2021
[2]
Dec. 10, 2021
Accelerated Share Repurchases [Line Items]              
Stock repurchase program authorized amount             $ 1,000,000
Remaining amount available for further repurchases     $ 242,700   $ 242,700    
Purchases of treasury stock (in shares)     715 [1] 521 2,400 [1] 2,114  
Aggregate purchased shares     $ 217,266 [1] $ 140,000 $ 752,266 [1] $ 538,082  
Accelerated Share Repurchase Program May 2022              
Accelerated Share Repurchases [Line Items]              
Stock repurchase program authorized amount   $ 200,000          
Prepayment to repurchase stock   200,000          
Initial share delivery   $ 160,000          
Accelerated Share Repurchase Program May 2022 | Subsequent Event              
Accelerated Share Repurchases [Line Items]              
Stock repurchase program, prepayment during prior period, future derivative settlement $ 40,000            
Purchases of treasury stock (in shares) 600            
Purchases of treasury stock (in USD per share) $ 320.24            
Open Market Purchase              
Accelerated Share Repurchases [Line Items]              
Purchases of treasury stock (in shares)     200        
Purchases of treasury stock (in USD per share)     $ 298.50        
Aggregate purchased shares     $ 57,300        
[1] Excluded the 101,821 shares and $40.0 million equity forward contract from the May 2022 ASR settled in August 2022.
[2] Excluded the 99,573 shares and $35.0 million equity forward contract from the June 2021 ASR settled in August 2021.
v3.22.2.2
Stock Repurchase Program - Stock Repurchase Activities (Detail) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 31, 2022
Aug. 20, 2021
Jul. 31, 2022
[1]
Jul. 31, 2021
[2]
Jul. 31, 2022
[1]
Jul. 31, 2021
[2]
Stock Repurchase Program [Abstract]            
Purchases of treasury stock (in shares)     715,000 521,000 2,400,000 2,114,000
Aggregate purchased shares     $ 217,266 $ 140,000 $ 752,266 $ 538,082
Reissuance of treasury stock     764,000 564,000 2,342,000 2,093,000
Accelerated Share Repurchases [Line Items]            
Share repurchases settlement of equity forward (in shares)   99,573        
Subsequent Event            
Accelerated Share Repurchases [Line Items]            
Share repurchases settlement of equity forward (in shares) 101,821          
June 2021, ASR            
Accelerated Share Repurchases [Line Items]            
Stock repurchase program, prepayment during period, derivative settlement   $ 35,000        
May 2022, ASR | Subsequent Event            
Stock Repurchase Program [Abstract]            
Purchases of treasury stock (in shares) 600,000          
Accelerated Share Repurchases [Line Items]            
Stock repurchase program, prepayment during period, derivative settlement $ 40,000          
[1] Excluded the 101,821 shares and $40.0 million equity forward contract from the May 2022 ASR settled in August 2022.
[2] Excluded the 99,573 shares and $35.0 million equity forward contract from the June 2021 ASR settled in August 2021.
v3.22.2.2
Stock-Based Compensation - Stock Compensation Expense (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Jul. 31, 2022
Jul. 31, 2021
Jul. 31, 2022
Jul. 31, 2021
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Stock-based compensation expense before taxes [1] $ 127,605 $ 85,162 $ 333,437 $ 248,530
Income tax benefit (20,940) (13,277) (54,717) (38,746)
Stock-based compensation expense after taxes $ 106,665 71,885 $ 278,720 209,784
Restricted Stock Units (RSUs), Market-based        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Grant date fair value (in USD per share)     $ 280.82  
Expected volatility     33.01%  
Risk-free interest rate     1.33%  
Expected term     1 year 8 months 8 days  
Restricted Stock Units (RSUs), Market-based | Maximum        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Target number of initial award earned, percentage 187.50%   187.50%  
Cost of products        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Stock-based compensation expense before taxes $ 15,318 9,582 $ 39,603 28,238
Cost of maintenance and service        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Stock-based compensation expense before taxes 6,859 3,446 17,335 10,192
Research and development expense        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Stock-based compensation expense before taxes 68,243 42,430 175,892 124,231
Sales and marketing expense        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Stock-based compensation expense before taxes 22,998 15,330 60,090 45,040
General and administrative expense        
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]        
Stock-based compensation expense before taxes $ 14,187 $ 14,374 $ 40,517 $ 40,829
[1] During the three and nine months ended July 31, 2022, we recognized stock-based compensation expense relating to restricted stock units (RSUs), granted to senior executives in February 2022 with certain market, performance and service conditions (market-based RSUs). Under the award agreements, the vesting of the market-based RSUs is contingent on achieving total stockholder return (TSR) relative to a peer index as well as revenue growth metrics. The performance period during which the achievement goals will be measured is fiscal 2022 and fiscal 2023. The maximum potential awards that may be earned are 187.5% of the target number of the initial awards. The awards will vest in equal increments in December 2023 and December 2024 if the TSR target, revenue growth metrics, and service conditions are achieved. The grant date fair value for the market-based RSUs of $280.82 was determined using a Monte Carlo simulation model with the following assumptions: expected volatility of 33.01%, risk-free interest rate of 1.33% and an expected term of 1.69 years.
v3.22.2.2
Stock-Based Compensation - Additional Information (Detail)
$ in Millions
3 Months Ended
Jul. 31, 2022
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unamortized share-based compensation expense $ 1,057.7
Weighted-average period of total compensation costs to be recognized in years 2 years 4 months 24 days
ESPP  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unamortized share-based compensation expense $ 59.7
Weighted-average period of total compensation costs to be recognized in years 2 years
v3.22.2.2
Stock-Based Compensation - Schedule of Intrinsic Value of Equity Awards Exercised (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jul. 31, 2022
Jul. 31, 2021
Jul. 31, 2022
Jul. 31, 2021
Stock Compensation [Abstract]        
Intrinsic value of awards exercised $ 86,080 $ 30,896 $ 245,468 $ 143,100
v3.22.2.2
Net Income per Share - Reconciliation of Weighted Average Common Shares Used to Calculate Basic Net Income Per Share (Detail) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Jul. 31, 2022
Jul. 31, 2021
Jul. 31, 2022
Jul. 31, 2021
Numerator:        
Net income attributed to Synopsys $ 222,626 $ 198,646 $ 831,094 $ 556,069
Denominator:        
Weighted-average common shares for basic net income per share (shares) 152,938 152,635 153,082 152,619
Dilutive effect of common share equivalents (shares) 2,868 4,272 3,463 4,539
Weighted-average common shares for diluted net income per share (shares) 155,806 156,907 156,545 157,158
Net income per share attributed to Synopsys:        
Basic (in USD per share) $ 1.46 $ 1.30 $ 5.43 $ 3.64
Diluted (in USD per share) $ 1.43 $ 1.27 $ 5.31 $ 3.54
Anti-dilutive employee stock-based awards excluded (shares) 336 355 268 405
v3.22.2.2
Segment Disclosure - Additional information (Detail)
9 Months Ended
Jul. 31, 2022
Segment
Segment Reporting [Abstract]  
Number of reportable operating segment 2
v3.22.2.2
Segment Disclosure - Schedule of Segment Reporting Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jul. 31, 2022
Jul. 31, 2021
Jul. 31, 2022
Jul. 31, 2021
Segment Reporting Information [Line Items]        
Total revenue $ 1,247,766 $ 1,057,130 $ 3,797,250 $ 3,051,774
Adjusted operating income 233,928 201,923 944,665 544,502
Operating Segments        
Segment Reporting Information [Line Items]        
Adjusted operating income $ 392,127 $ 337,396 $ 1,321,671 $ 941,456
Adjusted operating margin 31.00% 32.00% 35.00% 31.00%
Operating Segments | Semiconductor & System Design:        
Segment Reporting Information [Line Items]        
Total revenue $ 1,129,427 $ 959,155 $ 3,458,499 $ 2,767,950
Adjusted operating income $ 380,871 $ 328,742 $ 1,285,391 $ 916,434
Adjusted operating margin 34.00% 34.00% 37.00% 33.00%
Operating Segments | Software Integrity:        
Segment Reporting Information [Line Items]        
Total revenue $ 118,339 $ 97,975 $ 338,751 $ 283,824
Adjusted operating income $ 11,256 $ 8,654 $ 36,280 $ 25,022
Adjusted operating margin 10.00% 9.00% 11.00% 9.00%
v3.22.2.2
Segment Disclosure - Schedule of Segment Reconciliation (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jul. 31, 2022
Jul. 31, 2021
Jul. 31, 2022
Jul. 31, 2021
Segment Reporting Information [Line Items]        
Operating income $ 233,928 $ 201,923 $ 944,665 $ 544,502
Amortization of intangible expense (27,073) (21,450) (72,233) (63,557)
Stock-based compensation expense [1] (127,605) (85,162) (333,437) (248,530)
Operating Segments        
Segment Reporting Information [Line Items]        
Operating income 392,127 337,396 1,321,671 941,456
Reconciling items:        
Segment Reporting Information [Line Items]        
Amortization of intangible expense (26,454) (20,440) (70,181) (60,437)
Stock-based compensation expense (127,605) (85,162) (333,437) (248,530)
Other $ (4,140) $ (29,871) $ 26,612 $ (87,987)
[1] During the three and nine months ended July 31, 2022, we recognized stock-based compensation expense relating to restricted stock units (RSUs), granted to senior executives in February 2022 with certain market, performance and service conditions (market-based RSUs). Under the award agreements, the vesting of the market-based RSUs is contingent on achieving total stockholder return (TSR) relative to a peer index as well as revenue growth metrics. The performance period during which the achievement goals will be measured is fiscal 2022 and fiscal 2023. The maximum potential awards that may be earned are 187.5% of the target number of the initial awards. The awards will vest in equal increments in December 2023 and December 2024 if the TSR target, revenue growth metrics, and service conditions are achieved. The grant date fair value for the market-based RSUs of $280.82 was determined using a Monte Carlo simulation model with the following assumptions: expected volatility of 33.01%, risk-free interest rate of 1.33% and an expected term of 1.69 years.
v3.22.2.2
Segment Disclosure - Revenues Related to Operations by Geographic Areas (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jul. 31, 2022
Jul. 31, 2021
Jul. 31, 2022
Jul. 31, 2021
Schedule of Revenues from External Customers [Line Items]        
Total revenue $ 1,247,766 $ 1,057,130 $ 3,797,250 $ 3,051,774
United States        
Schedule of Revenues from External Customers [Line Items]        
Total revenue 575,326 477,218 1,763,541 1,417,636
Europe        
Schedule of Revenues from External Customers [Line Items]        
Total revenue 127,288 112,877 376,195 324,212
China        
Schedule of Revenues from External Customers [Line Items]        
Total revenue 189,138 164,172 617,524 405,460
Korea        
Schedule of Revenues from External Customers [Line Items]        
Total revenue 125,307 110,536 358,871 314,178
Other        
Schedule of Revenues from External Customers [Line Items]        
Total revenue $ 230,707 $ 192,327 $ 681,119 $ 590,288
v3.22.2.2
Other Income (Expense), Net - Components of Other Income (Expense), Net (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jul. 31, 2022
Jul. 31, 2021
Jul. 31, 2022
Jul. 31, 2021
Other Income (Expense)        
Interest income $ 2,735 $ 657 $ 4,876 $ 1,413
Interest expense (439) (757) (1,339) (2,301)
Gains (losses) on assets related to deferred compensation plan (1,092) 10,473 (50,001) 62,697
Foreign currency exchange gains (losses) (376) 2,756 3,452 5,283
Other, net 1,598 (1,715) 1,732 (5,158)
Total $ 2,426 $ 11,414 $ (41,280) $ 61,934
v3.22.2.2
Income Taxes - Provision for Income Taxes and Effective Tax Rates (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jul. 31, 2022
Jul. 31, 2021
Jul. 31, 2022
Jul. 31, 2021
Income Tax Disclosure [Abstract]        
Income before income taxes $ 236,354 $ 213,337 $ 903,385 $ 606,436
Provision for income taxes $ 16,708 $ 14,945 $ 76,506 $ 51,214
Effective tax rate 7.10% 7.00% 8.50% 8.40%
v3.22.2.2
Income Taxes - Additional Information (Detail) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Jul. 31, 2017
Apr. 30, 2019
Jul. 31, 2022
Taxes [Line Items]      
Statutory federal income tax rate     21.00%
Minimum      
Taxes [Line Items]      
Estimated potential decrease in underlying unrecognized tax benefits     $ 0
Maximum      
Taxes [Line Items]      
Estimated potential decrease in underlying unrecognized tax benefits     $ 33,000,000
Synopsys Hungary | Foreign Tax Authority | Tax Year 2011 - Tax Year 2013 | Hungarian Tax Authority      
Taxes [Line Items]      
Aggregate tax assessment $ 25,000,000    
Estimate of additional penalties and interest $ 11,000,000    
Unrecognized tax benefits   $ 17,400,000